| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | TNIK ERBB2 ATR MARK1 NEK10 OBSCN PTK6 NEK4 BRAF NPR2 FLT4 BMP2K CAMK2B RIPK4 YES1 NEK8 PAK1 PAK2 PNCK LYN HCK | 2.84e-06 | 600 | 218 | 21 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TNIK ERBB2 ATR MARK1 NEK10 OBSCN PTK6 NEK4 BRAF PI4KA NPR2 FLT4 BMP2K CAMK2B DGKE RIPK4 YES1 NEK8 PAK1 PAK2 PNCK LYN HCK | 3.34e-06 | 709 | 218 | 23 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | TNIK ERBB2 ATR MARK1 NEK10 OBSCN PTK6 NEK4 BRAF PI4KA NPR2 FLT4 BMP2K CAMK2B DGKE RIPK4 YES1 NEK8 PAK1 PAK2 PNCK LYN HCK | 1.13e-05 | 764 | 218 | 23 | GO:0016301 |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.19e-05 | 28 | 218 | 5 | GO:0141052 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.20e-05 | 98 | 218 | 8 | GO:0051213 | |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 1.27e-05 | 14 | 218 | 4 | GO:0032454 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 2.00e-05 | 31 | 218 | 5 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 2.35e-05 | 32 | 218 | 5 | GO:0140457 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TNIK PIGN ERBB2 ATR MARK1 NEK10 OBSCN PTK6 NEK4 BRAF PI4KA NPR2 FLT4 BMP2K CAMK2B DGKE RIPK4 YES1 NEK8 PAK1 PAK2 TNKS PNCK LYN HCK | 3.58e-05 | 938 | 218 | 25 | GO:0016772 |
| GeneOntologyMolecularFunction | protein serine kinase activity | TNIK ATR MARK1 NEK10 OBSCN NEK4 BRAF BMP2K CAMK2B RIPK4 NEK8 PAK1 PAK2 PNCK | 4.85e-05 | 363 | 218 | 14 | GO:0106310 |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 7.63e-05 | 65 | 218 | 6 | GO:0016706 | |
| GeneOntologyMolecularFunction | demethylase activity | 1.14e-04 | 44 | 218 | 5 | GO:0032451 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.29e-04 | 102 | 218 | 7 | GO:0043178 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 2.69e-04 | 192 | 218 | 9 | GO:0008234 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.91e-04 | 194 | 218 | 9 | GO:0016705 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 3.53e-04 | 3 | 218 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TNIK ATR MARK1 NEK10 OBSCN NEK4 BRAF BMP2K CAMK2B RIPK4 NEK8 PAK1 PAK2 PNCK | 4.12e-04 | 446 | 218 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GAPDH MARK1 MTSS1 OBSCN MYPN MID1 DMD TBCE EZR FLNB ABI1 MID2 CAMK2B CAPN2 ARFGEF2 ACTR2 PHPT1 ARHGEF10 CSRP1 CSRP2 ENAH SORBS3 PAK1 DNM3 LYN | 4.19e-04 | 1099 | 218 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 4.27e-04 | 14 | 218 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 4.41e-04 | 33 | 218 | 4 | GO:0050681 | |
| GeneOntologyMolecularFunction | lipid binding | CYP4F8 GGA2 MARK1 MTSS1 OBSCN PLA2G15 ITPR1 ITPR2 FCHSD2 OSBPL2 PROM2 KCNJ1 OSBPL7 OSBPL6 UGT2B15 UGT2B17 C3 BPIFB3 RPH3A SH3PXD2A LYN HCK SEC14L2 | 5.24e-04 | 988 | 218 | 23 | GO:0008289 |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 6.12e-04 | 95 | 218 | 6 | GO:0005546 | |
| GeneOntologyMolecularFunction | protein-phosphatidylethanolamide deconjugating activity | 7.02e-04 | 4 | 218 | 2 | GO:0019786 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 7.79e-04 | 17 | 218 | 3 | GO:0004198 | |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 1.16e-03 | 5 | 218 | 2 | GO:0140683 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.22e-03 | 43 | 218 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | transition metal ion binding | KDM3A CYP4F8 QPCTL KDM4C CYP46A1 PLA2G15 BHMT NEK4 MID1 AHCY DMD UROD MMP13 P4HA2 MID2 KDM5A NSD1 FBXO11 RPH3A LIG3 TMLHE CSRP1 OTUD7A CYP2U1 TNKS | 1.29e-03 | 1189 | 218 | 25 | GO:0046914 |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 1.57e-03 | 46 | 218 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 1.81e-03 | 117 | 218 | 6 | GO:0051219 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | TNIK ERBB2 SEMA3G ITPR1 SLIT2 KIDINS220 BRAF MYPN DMD TBCE EZR CACNA1F FLNB NPR2 ABI1 CAMK2B OBSL1 LAMA5 MED1 JMJD1C ACTR2 WDR19 ENAH PAK1 LRP1 DNM3 PAK2 LYN HCK TOP2B | 8.51e-06 | 1194 | 217 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TNIK MTSS1 OBSCN SLIT2 FCHSD2 BRAF MYPN EZR FLNB ABI1 OBSL1 ACTR2 PHPT1 ARHGEF10 CSRP1 CSRP2 ENAH SORBS3 PAK1 LRP1 PAK2 TLE6 HCK | 1.39e-05 | 803 | 217 | 23 | GO:0030036 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 3.14e-05 | 228 | 217 | 11 | GO:0046777 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | ERBB2 QPCTL ATR GAPDH MARK1 PTK6 BRAF DMD RGPD2 P4HA2 FLT4 ABI1 DPY19L1 FOLH1 CAMK2B PRDX4 NSD1 UBA2 YES1 PAK1 PAK2 TNKS PNCK LYN HCK | 3.74e-05 | 976 | 217 | 25 | GO:0018193 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TNIK ERBB2 SEMA3G SLIT2 KIDINS220 BRAF MYPN DMD TBCE CACNA1F NPR2 ABI1 CAMK2B OBSL1 LAMA5 ACTR2 ENAH PAK1 LRP1 DNM3 PAK2 TOP2B | 4.13e-05 | 802 | 217 | 22 | GO:0048812 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TNIK ERBB2 SEMA3G SLIT2 KIDINS220 BRAF MYPN TBCE CACNA1F NPR2 ABI1 CAMK2B OBSL1 LAMA5 ACTR2 ENAH PAK1 LRP1 DNM3 PAK2 TOP2B | 4.47e-05 | 748 | 217 | 21 | GO:0048667 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TNIK ERBB2 SEMA3G SLIT2 KIDINS220 BRAF MYPN DMD TBCE CACNA1F NPR2 ABI1 CAMK2B OBSL1 LAMA5 ACTR2 ENAH PAK1 LRP1 DNM3 PAK2 TOP2B | 5.63e-05 | 819 | 217 | 22 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TNIK ERBB2 SEMA3G SLIT2 KIDINS220 BRAF MYPN DMD TBCE CACNA1F NPR2 ABI1 CAMK2B OBSL1 LAMA5 ACTR2 ENAH PAK1 LRP1 DNM3 PAK2 TOP2B | 6.38e-05 | 826 | 217 | 22 | GO:0048858 |
| GeneOntologyBiologicalProcess | actin filament-based process | TNIK MTSS1 OBSCN SLIT2 FCHSD2 BRAF MYPN EZR FLNB ABI1 OBSL1 ACTR2 PHPT1 ARHGEF10 CSRP1 CSRP2 ENAH SORBS3 PAK1 LRP1 PAK2 TLE6 HCK | 9.83e-05 | 912 | 217 | 23 | GO:0030029 |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 1.09e-04 | 218 | 217 | 10 | GO:0006575 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | TNIK SEMA3G CASZ1 SLIT2 BRAF CAMK2B OBSL1 CTDSP1 ACTR2 HAPLN1 SNW1 PAK1 LRP1 TLE6 LYN SORL1 | 1.18e-04 | 515 | 217 | 16 | GO:0050767 |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 1.27e-04 | 25 | 217 | 4 | GO:0038096 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 1.27e-04 | 25 | 217 | 4 | GO:0002433 | |
| GeneOntologyCellularComponent | nuclear membrane | GAPDH RB1CC1 ITPR1 TNRC18 OSBPL7 OSBPL6 UGT2B15 UGT2B17 NOC4L RGPD2 DPY19L1 PAK1 TNKS | 8.93e-05 | 349 | 220 | 13 | GO:0031965 |
| GeneOntologyCellularComponent | Z disc | 2.03e-04 | 151 | 220 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | perinuclear endoplasmic reticulum | 2.31e-04 | 29 | 220 | 4 | GO:0097038 | |
| GeneOntologyCellularComponent | anchoring junction | MTSS1 OBSCN FCHSD2 PI4KA DMD MMP13 EZR FLNB KRT18 CAPN2 OBSL1 YES1 ACTR2 SH3PXD2A CSRP1 CSRP2 ENAH SORBS3 PAK1 LRP1 PAK2 LYN HCK | 2.66e-04 | 976 | 220 | 23 | GO:0070161 |
| GeneOntologyCellularComponent | cell-substrate junction | PI4KA DMD EZR FLNB CAPN2 YES1 ACTR2 CSRP1 CSRP2 ENAH SORBS3 PAK1 LRP1 HCK | 2.68e-04 | 443 | 220 | 14 | GO:0030055 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 3.05e-04 | 56 | 220 | 5 | GO:0099091 | |
| GeneOntologyCellularComponent | nuclear envelope | CALR3 ATR GAPDH RB1CC1 ITPR1 TNRC18 OSBPL7 OSBPL6 UGT2B15 UGT2B17 NOC4L RGPD2 DPY19L1 PAK1 TNKS SORL1 | 3.07e-04 | 560 | 220 | 16 | GO:0005635 |
| GeneOntologyCellularComponent | I band | 3.85e-04 | 166 | 220 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | postsynapse | TNIK ERBB2 ATR GAPDH MARK1 ANKS1B CYP46A1 CHRNA5 ITPR1 DMD ABI1 CAMK2B CAPN2 ARFGEF2 GRIA4 YES1 RPH3A ACTR2 PAK1 LRP1 DNM3 PAK2 LYN | 4.81e-04 | 1018 | 220 | 23 | GO:0098794 |
| GeneOntologyCellularComponent | microspike | 6.52e-04 | 4 | 220 | 2 | GO:0044393 | |
| GeneOntologyCellularComponent | focal adhesion | PI4KA EZR FLNB CAPN2 YES1 ACTR2 CSRP1 CSRP2 ENAH SORBS3 PAK1 LRP1 HCK | 6.83e-04 | 431 | 220 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | postsynaptic specialization | TNIK GAPDH ANKS1B ITPR1 DMD ABI1 CAMK2B GRIA4 YES1 PAK1 LRP1 DNM3 PAK2 LYN | 9.35e-04 | 503 | 220 | 14 | GO:0099572 |
| HumanPheno | Vascular dilatation | PIGN CASZ1 LUZP1 BRAF MYPN MID1 FLNB P4HA2 NSD1 ARFGEF2 FBXO11 WDR19 GTF2I LYN | 1.14e-05 | 215 | 86 | 14 | HP:0002617 |
| HumanPheno | Aortic dilatation | PIGN CASZ1 LUZP1 MYPN MID1 FLNB P4HA2 NSD1 ARFGEF2 FBXO11 GTF2I LYN | 2.05e-05 | 168 | 86 | 12 | HP:0001724 |
| HumanPheno | Aortic aneurysm | PIGN CASZ1 LUZP1 MYPN MID1 FLNB P4HA2 NSD1 ARFGEF2 FBXO11 GTF2I LYN | 2.05e-05 | 168 | 86 | 12 | HP:0004942 |
| Domain | Kinase-like_dom | TNIK ERBB2 ATR MARK1 NEK10 OBSCN PTK6 NEK4 BRAF PI4KA DMD NPR2 FLT4 BMP2K CAMK2B CHD9 RIPK4 YES1 NEK8 PAK1 DNM3 PAK2 PNCK LYN HCK | 5.69e-09 | 542 | 219 | 25 | IPR011009 |
| Domain | Prot_kinase_dom | TNIK ERBB2 MARK1 NEK10 OBSCN PTK6 NEK4 BRAF NPR2 FLT4 BMP2K CAMK2B RIPK4 YES1 NEK8 PAK1 PAK2 PNCK LYN HCK | 1.37e-06 | 489 | 219 | 20 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | TNIK ERBB2 MARK1 NEK10 OBSCN PTK6 NEK4 BRAF NPR2 FLT4 BMP2K CAMK2B RIPK4 YES1 NEK8 PAK1 PAK2 PNCK LYN HCK | 1.55e-06 | 493 | 219 | 20 | PS50011 |
| Domain | PROTEIN_KINASE_ATP | TNIK ERBB2 MARK1 NEK10 OBSCN PTK6 NEK4 BRAF FLT4 BMP2K CAMK2B RIPK4 YES1 NEK8 PAK1 PAK2 PNCK LYN HCK | 2.13e-06 | 459 | 219 | 19 | PS00107 |
| Domain | Protein_kinase_ATP_BS | TNIK ERBB2 MARK1 NEK10 OBSCN PTK6 NEK4 BRAF FLT4 CAMK2B YES1 NEK8 PAK1 PAK2 PNCK LYN HCK | 2.57e-06 | 379 | 219 | 17 | IPR017441 |
| Domain | JmjC | 7.51e-06 | 24 | 219 | 5 | PF02373 | |
| Domain | PROTEIN_KINASE_TYR | 1.86e-05 | 97 | 219 | 8 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.86e-05 | 97 | 219 | 8 | IPR008266 | |
| Domain | JMJC | 3.29e-05 | 32 | 219 | 5 | PS51184 | |
| Domain | JmjC_dom | 3.29e-05 | 32 | 219 | 5 | IPR003347 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.68e-05 | 138 | 219 | 9 | IPR001245 | |
| Domain | JmjC | 3.85e-05 | 33 | 219 | 5 | SM00558 | |
| Domain | ConA-like_dom | CALR3 SLIT2 MAMDC2 MID1 SEL1L3 COL14A1 SPSB4 MID2 SPSB1 LAMA5 HNRNPUL2 | 5.75e-05 | 219 | 219 | 11 | IPR013320 |
| Domain | - | AZGP1 OBSCN CEACAM4 SEMA3G IL18RAP MYPN MID1 SPACA6 COL14A1 IGSF3 FLNB FLT4 MID2 OBSL1 FCRL6 IGDCC4 HAPLN1 TGM7 LY9 SORL1 | 1.11e-04 | 663 | 219 | 20 | 2.60.40.10 |
| Domain | Pkinase_Tyr | 1.42e-04 | 129 | 219 | 8 | PF07714 | |
| Domain | - | SEMA3G HIRA NWD2 IFT80 WDR17 BTRC ANAPC4 RBBP7 WDR19 STRAP ARHGEF10 TLE6 MAPKBP1 | 1.62e-04 | 333 | 219 | 13 | 2.130.10.10 |
| Domain | Pkinase | TNIK MARK1 NEK10 OBSCN NEK4 BRAF NPR2 BMP2K CAMK2B RIPK4 NEK8 PAK1 PAK2 PNCK | 1.71e-04 | 381 | 219 | 14 | PF00069 |
| Domain | WD40/YVTN_repeat-like_dom | SEMA3G HIRA NWD2 IFT80 WDR17 BTRC ANAPC4 RBBP7 WDR19 STRAP ARHGEF10 TLE6 MAPKBP1 | 1.71e-04 | 335 | 219 | 13 | IPR015943 |
| Domain | WD40_repeat_dom | HIRA NWD2 IFT80 WDR17 BTRC ANAPC4 RBBP7 WDR19 STRAP ARHGEF10 TLE6 MAPKBP1 | 2.10e-04 | 297 | 219 | 12 | IPR017986 |
| Domain | Ig-like_fold | AZGP1 OBSCN CEACAM4 SEMA3G IL18RAP MYPN MID1 SPACA6 COL14A1 IGSF3 FLNB FLT4 MID2 OBSL1 FCRL6 IGDCC4 HAPLN1 TGM7 LY9 SORL1 | 2.55e-04 | 706 | 219 | 20 | IPR013783 |
| Domain | C2_III | 3.24e-04 | 12 | 219 | 3 | IPR033883 | |
| Domain | Calpain_III | 3.24e-04 | 12 | 219 | 3 | IPR022683 | |
| Domain | OSBP | 3.24e-04 | 12 | 219 | 3 | PS01013 | |
| Domain | calpain_III | 3.24e-04 | 12 | 219 | 3 | SM00720 | |
| Domain | Oxysterol-bd_CS | 3.24e-04 | 12 | 219 | 3 | IPR018494 | |
| Domain | Oxysterol_BP | 3.24e-04 | 12 | 219 | 3 | PF01237 | |
| Domain | Oxysterol-bd | 3.24e-04 | 12 | 219 | 3 | IPR000648 | |
| Domain | InsP3_rcpt-bd | 4.07e-04 | 3 | 219 | 2 | IPR000493 | |
| Domain | Calpain_III | 4.17e-04 | 13 | 219 | 3 | PF01067 | |
| Domain | Calpain_domain_III | 4.17e-04 | 13 | 219 | 3 | IPR022682 | |
| Domain | TPR-like_helical_dom | ATR CFAP54 TRANK1 SUGT1 SEL1L3 ANAPC5 RGPD2 P4HA2 WDR19 CAPN7 | 4.42e-04 | 233 | 219 | 10 | IPR011990 |
| Domain | Calpain_cysteine_protease | 5.26e-04 | 14 | 219 | 3 | IPR022684 | |
| Domain | Tyr_kinase_cat_dom | 5.91e-04 | 88 | 219 | 6 | IPR020635 | |
| Domain | TyrKc | 5.91e-04 | 88 | 219 | 6 | SM00219 | |
| Domain | Peptidase_C2 | 6.52e-04 | 15 | 219 | 3 | PF00648 | |
| Domain | Peptidase_C2_calpain_cat | 6.52e-04 | 15 | 219 | 3 | IPR001300 | |
| Domain | CysPc | 6.52e-04 | 15 | 219 | 3 | SM00230 | |
| Domain | CALPAIN_CAT | 6.52e-04 | 15 | 219 | 3 | PS50203 | |
| Domain | SH3_1 | 7.18e-04 | 164 | 219 | 8 | PF00018 | |
| Domain | - | 7.74e-04 | 207 | 219 | 9 | 1.25.40.10 | |
| Domain | Peptidase_C54 | 8.09e-04 | 4 | 219 | 2 | PF03416 | |
| Domain | Peptidase_C54 | 8.09e-04 | 4 | 219 | 2 | IPR005078 | |
| Domain | SH3 | 1.05e-03 | 216 | 219 | 9 | PS50002 | |
| Domain | SH3 | 1.05e-03 | 216 | 219 | 9 | SM00326 | |
| Domain | Ser/Thr_kinase_AS | TNIK MARK1 OBSCN NEK4 BRAF BMP2K CAMK2B RIPK4 NEK8 PAK1 PAK2 PNCK | 1.08e-03 | 357 | 219 | 12 | IPR008271 |
| Domain | S_TKc | TNIK MARK1 NEK10 OBSCN NEK4 BRAF BMP2K CAMK2B NEK8 PAK1 PAK2 PNCK | 1.13e-03 | 359 | 219 | 12 | SM00220 |
| Domain | SH3_domain | 1.19e-03 | 220 | 219 | 9 | IPR001452 | |
| Domain | LDLR_class-A_CS | 1.21e-03 | 40 | 219 | 4 | IPR023415 | |
| Domain | PROTEIN_KINASE_ST | TNIK MARK1 OBSCN NEK4 BRAF BMP2K CAMK2B RIPK4 NEK8 PAK1 PAK2 PNCK | 1.22e-03 | 362 | 219 | 12 | PS00108 |
| Domain | WD40 | 1.29e-03 | 268 | 219 | 10 | SM00320 | |
| Domain | WD40_repeat | 1.44e-03 | 272 | 219 | 10 | IPR001680 | |
| Domain | PWWP | 1.56e-03 | 20 | 219 | 3 | SM00293 | |
| Domain | WD_REPEATS_1 | 1.69e-03 | 278 | 219 | 10 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.74e-03 | 279 | 219 | 10 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.74e-03 | 279 | 219 | 10 | PS50294 | |
| Domain | Znf_FYVE_PHD | 1.76e-03 | 147 | 219 | 7 | IPR011011 | |
| Domain | Ldl_recept_a | 1.88e-03 | 45 | 219 | 4 | PF00057 | |
| Domain | Clathrin_mu_CS | 1.99e-03 | 6 | 219 | 2 | IPR018240 | |
| Domain | PAK_BD | 1.99e-03 | 6 | 219 | 2 | IPR033923 | |
| Domain | Ryanodine_recept-rel | 1.99e-03 | 6 | 219 | 2 | IPR015925 | |
| Domain | - | 1.99e-03 | 6 | 219 | 2 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 1.99e-03 | 6 | 219 | 2 | IPR013662 | |
| Domain | CLAT_ADAPTOR_M_1 | 1.99e-03 | 6 | 219 | 2 | PS00990 | |
| Domain | CLAT_ADAPTOR_M_2 | 1.99e-03 | 6 | 219 | 2 | PS00991 | |
| Domain | Ins145_P3_rec | 1.99e-03 | 6 | 219 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.99e-03 | 6 | 219 | 2 | PF08454 | |
| Domain | RIH_dom | 1.99e-03 | 6 | 219 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.99e-03 | 6 | 219 | 2 | IPR014821 | |
| Domain | RYDR_ITPR | 1.99e-03 | 6 | 219 | 2 | PF01365 | |
| Domain | IG_LIKE | AZGP1 OBSCN CEACAM4 SEMA3G IL18RAP MYPN SPACA6 IGSF3 FLT4 OBSL1 FCRL6 IGDCC4 HAPLN1 LY9 | 2.04e-03 | 491 | 219 | 14 | PS50835 |
| Domain | - | 2.04e-03 | 46 | 219 | 4 | 4.10.400.10 | |
| Domain | PWWP | 2.37e-03 | 23 | 219 | 3 | PF00855 | |
| Domain | PWWP_dom | 2.37e-03 | 23 | 219 | 3 | IPR000313 | |
| Domain | LDLRA_1 | 2.39e-03 | 48 | 219 | 4 | PS01209 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 2.68e-05 | 30 | 170 | 5 | M76 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.37e-04 | 9 | 170 | 3 | M47852 | |
| Pathway | WP_FOCAL_ADHESION | 1.50e-04 | 199 | 170 | 10 | M39402 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.68e-04 | 129 | 170 | 8 | M186 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.75e-04 | 165 | 170 | 9 | MM15026 | |
| Pathway | PID_CDC42_PATHWAY | 1.95e-04 | 70 | 170 | 6 | M81 | |
| Pathway | SIG_CHEMOTAXIS | 1.99e-04 | 45 | 170 | 5 | M5193 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 2.31e-04 | 102 | 170 | 7 | M39577 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 2.88e-04 | 27 | 170 | 4 | M33 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 3.26e-04 | 219 | 170 | 10 | M29836 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.28e-04 | 261 | 170 | 11 | MM15676 | |
| Pathway | REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS | 3.33e-04 | 28 | 170 | 4 | M11362 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.39e-04 | 143 | 170 | 8 | M27107 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 3.50e-04 | 12 | 170 | 3 | MM1368 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 3.83e-04 | 29 | 170 | 4 | MM14934 | |
| Pubmed | CAPN12 KDM3A ERBB2 MARK1 KDM3B SEMA3G PTK6 BRAF AHCY MMP13 RBBP7 CAMK2B CAPN2 DUSP6 NSD1 DGKE YES1 ENTPD1 ENTPD2 PAK1 LRP1 PAK2 TGM7 LYN HCK | 1.36e-11 | 730 | 224 | 25 | 34857952 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | KDM3A AZGP1 KDM3B LUZP1 HIRA NUFIP2 AHCY EZR KRT18 RBBP7 SMCHD1 MED1 JMJD1C LIG3 GTF2I SNW1 PAK1 PAK2 EIF3F TOP2B | 1.38e-11 | 444 | 224 | 20 | 34795231 |
| Pubmed | TNIK ANKS1B PLA2G15 LUZP1 HIRA KCNJ1 PI4KA NUFIP2 NOP2 SH3BP5 EZR RGPD2 ABI1 KDM5A CAMK2B NSD1 DIDO1 GRIA4 RPH3A SNW1 STRAP HNRNPUL2 ENAH PAK1 LRP1 DNM3 PAK2 TNKS | 3.44e-11 | 963 | 224 | 28 | 28671696 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | PIGN QPCTL GAPDH AZGP1 ITIH2 LUZP1 ITPR2 NUFIP2 NIP7 AHCY AP1M1 C3 PISD C9 NOP2 EZR FLNB KRT18 PUF60 SMCHD1 DIDO1 ABCF2 ACTR2 GTF2I SNW1 KIN STRAP HNRNPUL2 TIMM50 MRPS34 EIF3F LYN | 3.71e-11 | 1257 | 224 | 32 | 36526897 |
| Pubmed | KDM3A KDM4C ANKS1B USP9Y TMEM222 AHCY C1S UROD WDR17 BTRC SH3BP5 EZR FLNB KDM5A FOLH1 ATP13A1 OBSL1 ARFGEF2 CHD9 FBXO11 CTDSP1 RIPK4 RPH3A WDR19 ARHGEF10 PAK1 LRP1 DNM3 PAK2 TNKS EIF3F | 2.89e-10 | 1285 | 224 | 31 | 35914814 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | KDM3A KDM3B CASZ1 HIRA NIP7 BRD1 NOP2 KDM5A RBBP7 SMCHD1 TOPBP1 NSD1 DIDO1 CHD9 MED1 FOXJ3 JMJD1C LIG3 GTF2I SNAPC4 TOP2B | 5.50e-10 | 608 | 224 | 21 | 36089195 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATR GAPDH AZGP1 PLA2G15 KIDINS220 PI4KA AHCY AP1M1 NOC4L ALDH2 NOP2 EZR FLNB ATP13A1 PUF60 CAMK2B APMAP SMCHD1 PRDX4 ABCF2 ACTR2 LIG3 PDE12 GTF2I SNW1 STRAP HNRNPUL2 CSRP2 ENAH TIMM50 MRPS34 TOP2B | 8.52e-10 | 1425 | 224 | 32 | 30948266 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATR MARK1 RB1CC1 LUZP1 PTK6 ITPR2 BRAF NUFIP2 AHCY ANAPC5 BTRC ANAPC4 BMP2K DPY19L1 RBBP7 CAMK2B PRDX4 OBSL1 YES1 SH3PXD2A CAPN7 DNM3 EIF3F LYN HCK | 1.33e-09 | 910 | 224 | 25 | 36736316 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | MARK1 AZGP1 ITPR2 GGH KIDINS220 PI4KA AHCY NOC4L C3 ALDH2 NOP2 EZR P4HA2 PUF60 YES1 SERPINA12 LIG3 STRAP HNRNPUL2 MRPS34 EIF3F HAL | 2.74e-09 | 732 | 224 | 22 | 34732716 |
| Pubmed | TNIK MARK1 ANKS1B LUZP1 ITPR2 NWD2 OSBPL6 PISD BMP2K PUF60 CAMK2B GRIA4 DGKE YES1 RPH3A ACTR2 HAPLN1 | 3.54e-09 | 430 | 224 | 17 | 32581705 | |
| Pubmed | KDM3A GAPDH KDM3B LUZP1 SUGT1 NUFIP2 EZR RBBP7 PUF60 SMCHD1 NSD1 DIDO1 MED1 JMJD1C GTF2I SNW1 STRAP ENAH PAK2 | 3.66e-09 | 549 | 224 | 19 | 38280479 | |
| Pubmed | TNIK GAPDH MARK1 ANKS1B ITPR1 TNRC18 SUGT1 BPHL PI4KA NUFIP2 AP1M1 BTRC IGSF3 ARMC6 RGPD2 FLNB ABI1 ATP13A1 CAMK2B CAPN2 GRIA4 RPH3A PHPT1 HNRNPUL2 ENAH TIMM50 CRYBG3 | 6.52e-09 | 1139 | 224 | 27 | 36417873 | |
| Pubmed | GAPDH AZGP1 ITPR1 AHCY C3 ALDH2 NOP2 EZR FLNB KRT18 RBBP7 SMCHD1 TOPBP1 DIDO1 ACTR2 SERPINA12 GTF2I SNW1 HNRNPUL2 TOP2B | 1.07e-08 | 652 | 224 | 20 | 31180492 | |
| Pubmed | 1.07e-08 | 25 | 224 | 6 | 16374509 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | GAPDH KDM3B IREB2 GGH SUGT1 AHCY AP1M1 UROD KYNU TBCE EZR FLNB KRT18 RBBP7 PUF60 PRDX4 CAPN2 ARFGEF2 UBA2 ABCF2 ACTR2 PDE12 GTF2I STRAP ARHGEF10 HNRNPUL2 CSRP1 ENAH PAK2 EIF3F | 2.08e-08 | 1455 | 224 | 30 | 22863883 |
| Pubmed | SUGT1 BRAF MYPN NUFIP2 NOP2 SH3BP5 FLNB TOPBP1 DIDO1 MED1 GTF2I HNRNPUL2 CSRP1 ENAH SORBS3 PAK1 PAK2 | 3.53e-08 | 503 | 224 | 17 | 16964243 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MARK1 USP9Y HIRA GGH NWD2 KIDINS220 MAMDC2 NOC4L EZR KDM5A PUF60 APMAP PRDX4 DIDO1 CHD9 FBXO11 MED1 LIG3 SNW1 KIN HNRNPUL2 DNM3 MRPS34 EIF3F TOP2B | 4.05e-08 | 1082 | 224 | 25 | 38697112 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GAPDH RB1CC1 ITPR2 SLIT2 PI4KA AHCY NOC4L NOP2 EZR FLNB KRT18 PUF60 APMAP SMCHD1 OBSL1 ABCF2 YES1 ACTR2 LIG3 SNW1 HNRNPUL2 TIMM50 LYN TOP2B | 5.93e-08 | 1024 | 224 | 24 | 24711643 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | QPCTL LUZP1 KIDINS220 C3 DMD NOP2 BTRC FLNB RBBP7 SMCHD1 PRDX4 CAPN2 DUSP6 OBSL1 UBA2 ABCF2 GTF2I SNW1 PHPT1 HNRNPUL2 LRP1 TNKS SORL1 | 9.96e-08 | 974 | 224 | 23 | 28675297 |
| Pubmed | QPCTL GAPDH PLA2G15 GGH SEL1L3 AHCY IGSF3 EZR APMAP SMCHD1 LAMA5 ABCF2 GTF2I STRAP TIMM50 LRP1 EIF3F SORL1 | 1.14e-07 | 613 | 224 | 18 | 22268729 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | LUZP1 KIDINS220 SUGT1 MYPN NUFIP2 FLNB KRT18 DIDO1 ABCF2 JMJD1C GTF2I SNW1 | 1.22e-07 | 256 | 224 | 12 | 33397691 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ERBB2 SLIT2 BPHL PROM2 OSBPL7 AP1M1 PISD IFT80 UROD NOP2 ANAPC5 BTRC TBCE BMP2K ATP13A1 DIDO1 CHD9 FOXJ3 PHPT1 SLC12A4 SORBS3 SEC14L2 | 1.70e-07 | 925 | 224 | 22 | 28986522 |
| Pubmed | HIRA ITPR1 ITPR2 GGH SUGT1 NIP7 NOC4L ALDH2 NOP2 BTRC FLNB KRT18 BMP2K RBBP7 PRDX4 ABCF2 DGKE YES1 ACTR2 LIG3 GTF2I STRAP HNRNPUL2 CSRP2 TIMM50 MRPS34 EIF3F TOP2B | 2.13e-07 | 1440 | 224 | 28 | 30833792 | |
| Pubmed | TNIK QPCTL GAPDH IREB2 ITIH2 LUZP1 BRAF NUFIP2 AHCY NOC4L COL14A1 NOP2 KDM5A ATP13A1 PUF60 APMAP SMCHD1 PRDX4 OBSL1 DIDO1 FBXO11 MED1 GTF2I SNW1 STRAP TIMM50 HAL | 2.79e-07 | 1371 | 224 | 27 | 36244648 | |
| Pubmed | TNIK GAPDH KDM3B RB1CC1 LUZP1 GGH KIDINS220 SUGT1 NUFIP2 AHCY NOC4L C3 PISD ARMC6 FLNB P4HA2 KRT18 SMCHD1 LAMA5 DIDO1 YES1 ACTR2 CSRP2 SORBS3 MRPS34 LYN | 3.38e-07 | 1297 | 224 | 26 | 33545068 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | KDM3B HIRA ITPR2 SUGT1 NUFIP2 PISD NOP2 SMCHD1 DIDO1 MED1 JMJD1C LIG3 TOP2B | 3.89e-07 | 341 | 224 | 13 | 32971831 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | GAPDH KDM3B NIP7 AP1M1 NOC4L NOP2 ARMC6 BMP2K KDM5A RBBP7 PUF60 SMCHD1 PRDX4 UBA2 DIDO1 ABCF2 ACTR2 GTF2I SNW1 HNRNPUL2 TIMM50 PAK2 ALDH4A1 EIF3F LYN TOP2B | 4.58e-07 | 1318 | 224 | 26 | 30463901 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | GAPDH AZGP1 PLA2G15 ITIH2 BHMT GGH PROM2 AHCY C3 C9 EZR MGAM FLNB FOLH1 SLC44A2 LAMA5 CTDSP1 ACTR2 CAPN7 ENTPD2 DNM3 LYN SEC14L2 | 5.15e-07 | 1070 | 224 | 23 | 23533145 |
| Pubmed | PIGN KDM3A QPCTL GAPDH LUZP1 ITPR1 ITPR2 KIDINS220 PI4KA NUFIP2 AP1M1 EZR DPY19L1 ATP13A1 APMAP ARFGEF2 ABCF2 DGKE MED1 ACTR2 GTF2I HNRNPUL2 ENTPD1 EIF3F | 6.40e-07 | 1168 | 224 | 24 | 19946888 | |
| Pubmed | 7.41e-07 | 49 | 224 | 6 | 34368113 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TNIK GAPDH KDM3B SUGT1 NUFIP2 AHCY NOP2 ANAPC4 KRT18 RBBP7 PUF60 SMCHD1 DIDO1 MED1 LIG3 GTF2I SNW1 STRAP ENAH PAK2 TOP2B | 8.13e-07 | 934 | 224 | 21 | 33916271 |
| Pubmed | KDM3A GAPDH KDM3B TNRC18 SUGT1 AHCY NOC4L NOP2 EZR PUF60 SMCHD1 UBA2 DIDO1 CHD9 MED1 FOXJ3 JMJD1C ACTR2 GTF2I SNW1 STRAP PAK2 TOP2B | 8.67e-07 | 1103 | 224 | 23 | 34189442 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | GAPDH AZGP1 RB1CC1 LUZP1 ITPR1 NUFIP2 C3 NOP2 EZR FLNB KRT18 BMP2K RBBP7 PUF60 OBSL1 ABCF2 ACTR2 GTF2I HNRNPUL2 CSRP1 HAL | 1.05e-06 | 949 | 224 | 21 | 36574265 |
| Pubmed | 1.05e-06 | 4 | 224 | 3 | 23593242 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | LUZP1 HIRA SLIT2 NUFIP2 NOP2 MID2 BMP2K KDM5A ABCF2 MED1 ACTR2 SNW1 KIN STRAP SH3PXD2A CSRP2 PAK2 TOP2B | 1.27e-06 | 724 | 224 | 18 | 36232890 |
| Pubmed | TNIK QPCTL RB1CC1 ITPR1 ITPR2 KIDINS220 SUGT1 PI4KA NIP7 NOC4L COL14A1 IFT80 ALDH2 NOP2 ATP13A1 PRDX4 OBSL1 DGKE YES1 WDR19 PDE12 SNW1 ARHGEF10 TIMM50 MRPS34 CRYBG3 TOP2B | 1.33e-06 | 1487 | 224 | 27 | 33957083 | |
| Pubmed | QPCTL CASZ1 LUZP1 HIRA KIDINS220 PI4KA NUFIP2 NIP7 NOC4L ANAPC5 ABI1 BMP2K KDM5A ATP13A1 RBBP7 PRDX4 TOPBP1 NSD1 LAMA5 DIDO1 FBXO11 ABCF2 MED1 YES1 FOXJ3 MRPS34 EIF3F | 1.51e-06 | 1497 | 224 | 27 | 31527615 | |
| Pubmed | LUZP1 PI4KA NUFIP2 NIP7 NOP2 EZR FLNB KRT18 RBBP7 SMCHD1 YES1 ACTR2 LIG3 STRAP HNRNPUL2 LYN TOP2B | 1.57e-06 | 660 | 224 | 17 | 32780723 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | KDM3B CASZ1 PUF60 SMCHD1 DIDO1 LIG3 GTF2I SNW1 HNRNPUL2 TOP2B | 1.84e-06 | 220 | 224 | 10 | 35785414 |
| Pubmed | 1.85e-06 | 32 | 224 | 5 | 23750785 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.16e-06 | 130 | 224 | 8 | 35545047 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 2.17e-06 | 33 | 224 | 5 | 26864203 | |
| Pubmed | BPHL NUFIP2 PISD FLNB KRT18 PUF60 PRDX4 ABCF2 LIG3 GTF2I PHPT1 HNRNPUL2 MRPS34 CYP2U1 | 2.22e-06 | 464 | 224 | 14 | 32457219 | |
| Pubmed | Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells. | 2.61e-06 | 5 | 224 | 3 | 11956071 | |
| Pubmed | 2.61e-06 | 5 | 224 | 3 | 11782428 | ||
| Pubmed | Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer. | 2.61e-06 | 5 | 224 | 3 | 19893451 | |
| Pubmed | PI4KA EZR FLNB CAPN2 YES1 ACTR2 CSRP1 CSRP2 ENAH SORBS3 LRP1 | 2.75e-06 | 285 | 224 | 11 | 21423176 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 2.79e-06 | 180 | 224 | 9 | 30110629 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ERBB2 OBSCN KDM3B CASZ1 HIRA ITPR2 TNRC18 PROM2 PI4KA IGSF3 ARSJ ATP13A1 PUF60 NSD1 ARFGEF2 LAMA5 SLC12A4 NEK8 ENTPD2 SORBS3 MAPKBP1 SNAPC4 | 3.20e-06 | 1105 | 224 | 22 | 35748872 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CYP4F8 QPCTL GAPDH RB1CC1 BRAF AHCY ARMC6 EZR BPIFB3 KRT18 PUF60 CAMK2B UBA2 DGKE JMJD1C ACTR2 LIG3 GTF2I STRAP TIMM50 PAK2 MRPS34 EIF3F LYN | 3.30e-06 | 1284 | 224 | 24 | 17353931 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PIGN ERBB2 QPCTL ATR GAPDH PLA2G15 CHRNA5 ITPR1 ITPR2 NEK4 GGH SEL1L3 IGSF3 P4HA2 DPY19L1 PRDX4 ARFGEF2 LAMA5 PLA2R1 STRAP HNRNPUL2 LRP1 SORL1 | 3.60e-06 | 1201 | 224 | 23 | 35696571 |
| Pubmed | ERBB2 GGA2 MTSS1 OBSCN IREB2 SEMA3G ITPR1 TNRC18 TRANK1 SUGT1 COL14A1 SPSB4 ZFP62 SH3BP5 RBBP7 PUF60 NSD1 DIDO1 ACTR2 PHPT1 ARHGEF10 SH3PXD2A CSRP2 | 4.35e-06 | 1215 | 224 | 23 | 15146197 | |
| Pubmed | GAPDH AZGP1 SUGT1 NUFIP2 AHCY AP1M1 NOC4L UROD NOP2 PUF60 UBA2 ABCF2 GTF2I SNW1 CSRP2 TOP2B | 4.77e-06 | 641 | 224 | 16 | 36057605 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | QPCTL GAPDH SLIT2 OSBPL2 PI4KA ANAPC5 KRT18 RBBP7 APMAP PRDX4 ABCF2 SNW1 TIMM50 MRPS34 EIF3F | 5.18e-06 | 571 | 224 | 15 | 37167062 |
| Pubmed | Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. | 5.20e-06 | 6 | 224 | 3 | 10861086 | |
| Pubmed | 5.20e-06 | 6 | 224 | 3 | 1720539 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | LUZP1 NEK4 SLIT2 NUFIP2 OSBPL6 COL14A1 C3 PISD IFT80 TBCE EZR P4HA2 ABI1 CAMK2B APMAP OBSL1 DGKE MED1 WDR19 GTF2I SH3PXD2A NEK8 ENAH SORL1 | 5.32e-06 | 1321 | 224 | 24 | 27173435 |
| Pubmed | GAPDH EDDM3A MGAM FLNB APMAP SLC44A2 UBA2 ACTR2 HNRNPUL2 SPACA1 | 5.54e-06 | 249 | 224 | 10 | 30097533 | |
| Pubmed | KDM3A GAPDH KDM3B LUZP1 NOP2 EZR FLNB ABI1 RBBP7 PUF60 MED1 GTF2I SNW1 ENAH | 5.99e-06 | 506 | 224 | 14 | 30890647 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | GAPDH AHCY NOP2 FLNB KRT18 PRDX4 YES1 ACTR2 LIG3 STRAP CSRP1 TIMM50 ALDH4A1 EIF3F LYN | 6.24e-06 | 580 | 224 | 15 | 35676659 |
| Pubmed | ANKS1B FER1L6 LUZP1 TNRC18 SLC22A14 NIP7 ALDH2 DMD EZR RGPD2 FLNB KRT18 KDM5A CAMK2B SMCHD1 PRDX4 SLC44A2 ABCF2 GRIA4 ACTR2 SLC12A4 SH3PXD2A ENTPD2 ATG4C TOP2B | 7.51e-06 | 1442 | 224 | 25 | 35575683 | |
| Pubmed | QPCTL AZGP1 SUGT1 DMD BTRC EZR RBBP7 PUF60 PRDX4 ARHGEF10 SH3PXD2A CSRP2 ENAH TIMM50 PAK1 DNM3 PAK2 TNKS SORL1 | 8.73e-06 | 916 | 224 | 19 | 32203420 | |
| Pubmed | 9.05e-06 | 7 | 224 | 3 | 10858437 | ||
| Pubmed | Proline-rich sequences that bind to Src homology 3 domains with individual specificities. | 9.05e-06 | 7 | 224 | 3 | 7536925 | |
| Pubmed | 9.05e-06 | 7 | 224 | 3 | 12538589 | ||
| Pubmed | QM, a putative tumor suppressor, regulates proto-oncogene c-yes. | 9.05e-06 | 7 | 224 | 3 | 12138090 | |
| Pubmed | HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication. | 9.20e-06 | 21 | 224 | 4 | 12734410 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KDM3A MARK1 AZGP1 KDM3B SUGT1 NUFIP2 BTRC EZR FLNB P4HA2 KRT18 RBBP7 FBXO11 PDE12 GTF2I ARHGEF10 LRP1 MRPS34 TNKS EIF3F | 9.20e-06 | 1005 | 224 | 20 | 19615732 |
| Pubmed | GGA2 MARK1 IREB2 LUZP1 SLIT2 KIDINS220 AHCY BMP2K DPY19L1 ATP13A1 RBBP7 PRDX4 YES1 SNW1 KIN STRAP CSRP2 ENAH SORBS3 ATG4C | 9.47e-06 | 1007 | 224 | 20 | 34597346 | |
| Pubmed | KDM3A ERBB2 GGA2 MTSS1 KDM3B TRANK1 IFT80 IGSF3 SMCHD1 TOPBP1 LAMA5 DIDO1 FOXJ3 WDR19 | 9.88e-06 | 529 | 224 | 14 | 14621295 | |
| Pubmed | 1.01e-05 | 327 | 224 | 11 | 31409639 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | GAPDH AZGP1 NUFIP2 NOC4L BRD1 NOP2 KRT18 RBBP7 PUF60 LIG3 GTF2I SNW1 HNRNPUL2 EIF3F TOP2B | 1.03e-05 | 605 | 224 | 15 | 28977666 |
| Pubmed | TDRD15 GAPDH AZGP1 GGH MYPN AHCY DMD NOP2 EZR RGPD2 FLNB KRT18 PUF60 HNRNPUL2 CSRP2 TIMM50 EIF3F HAL | 1.05e-05 | 844 | 224 | 18 | 25963833 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | GAPDH LUZP1 FLNB BMP2K DPY19L1 ATP13A1 ABCF2 CSRP1 TIMM50 TOP2B | 1.05e-05 | 268 | 224 | 10 | 33024031 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GAPDH GGH SLIT2 PROM2 AHCY AP1M1 ALDH2 C9 FLNB ABI1 MID2 CAPN2 SLC44A2 LAMA5 ACTR2 PHPT1 ARSF CAPN7 CSRP1 SORL1 | 1.08e-05 | 1016 | 224 | 20 | 19056867 |
| Pubmed | LUZP1 NUFIP2 NIP7 NOP2 FLNB KRT18 RBBP7 PUF60 LAMA5 ABCF2 GTF2I SNW1 STRAP JRK TIMM50 MRPS34 EIF3F TOP2B | 1.10e-05 | 847 | 224 | 18 | 35850772 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | KDM3B IREB2 USP9Y TNRC18 MID1 ANAPC4 DIDO1 ACTR2 SNW1 DNM3 HCK | 1.13e-05 | 331 | 224 | 11 | 19490893 |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | CAPN12 OBSCN BTRC EZR NPR2 RBBP7 SLC44A2 CTDSP1 MED1 YES1 ACTR2 SLC12A4 ARHGEF10 HNRNPUL2 SH3PXD2A CSRP1 ENAH OTUD7A MAPKBP1 SEC14L2 | 1.16e-05 | 1021 | 224 | 20 | 26760575 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATR CASZ1 HIRA NIP7 NOP2 ANAPC5 KRT18 KDM5A RBBP7 SMCHD1 TOPBP1 NSD1 DIDO1 FBXO11 ABCF2 MED1 JMJD1C LIG3 GTF2I SNW1 TIMM50 ZNF221 TOP2B | 1.20e-05 | 1294 | 224 | 23 | 30804502 |
| Pubmed | 1.21e-05 | 164 | 224 | 8 | 32409323 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | QPCTL GAPDH CASZ1 NUFIP2 NOC4L NOP2 ZFP62 ANAPC4 IGSF3 P4HA2 KRT18 BMP2K DPY19L1 RBBP7 APMAP FBXO11 ABCF2 DGKE JMJD1C LRP1 TNKS TOP2B | 1.21e-05 | 1203 | 224 | 22 | 29180619 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | CASZ1 HIRA PI4KA AHCY BTRC ARMC6 ABI1 KDM5A PUF60 OBSL1 FBXO11 FOXJ3 JMJD1C LIG3 HNRNPUL2 LRP1 TOP2B SORL1 | 1.28e-05 | 857 | 224 | 18 | 25609649 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ERBB2 OBSCN CASZ1 PTK6 TNRC18 KIDINS220 PROM2 SEL1L3 SPACA6 PISD FLNB MID2 FOLH1 CAMK2B APMAP SPSB1 CHD9 FOXJ3 JMJD1C USF3 GTF2I SH3PXD2A ENTPD1 ENAH LRP1 | 1.29e-05 | 1489 | 224 | 25 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB2 KDM3B LUZP1 NEK4 BRAF PI4KA OSBPL6 AP1M1 BRD1 ABI1 KRT18 KDM5A RBBP7 ARHGEF10 SH3PXD2A OTUD7A TIMM50 CRYBG3 | 1.37e-05 | 861 | 224 | 18 | 36931259 |
| Pubmed | 1.44e-05 | 8 | 224 | 3 | 10944468 | ||
| Pubmed | The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation. | 1.44e-05 | 8 | 224 | 3 | 21309750 | |
| Pubmed | Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. | 1.44e-05 | 8 | 224 | 3 | 16921024 | |
| Pubmed | 1.44e-05 | 8 | 224 | 3 | 32483152 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | BHMT ITPR1 SLIT2 NWD2 PI4KA NUFIP2 C3 NOP2 BTRC EZR SMCHD1 TNKS TOP2B | 1.45e-05 | 475 | 224 | 13 | 31040226 |
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 1.47e-05 | 221 | 224 | 9 | 31950832 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | GAPDH SLIT2 NUFIP2 NOC4L ALDH2 TBCE ARMC6 P4HA2 ABI1 RBBP7 PUF60 APMAP SNW1 PAK2 ALDH4A1 EIF3F | 1.52e-05 | 704 | 224 | 16 | 32994395 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GAPDH NIP7 AHCY AP1M1 NOP2 EZR FLNB KRT18 RBBP7 PUF60 SMCHD1 PRDX4 CAPN2 DIDO1 ABCF2 GTF2I SNW1 STRAP CSRP2 ENAH TIMM50 MRPS34 EIF3F TOP2B | 1.65e-05 | 1415 | 224 | 24 | 28515276 |
| Pubmed | 1.67e-05 | 83 | 224 | 6 | 11114734 | ||
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 1.77e-05 | 50 | 224 | 5 | 19807924 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | TNIK SUGT1 NUFIP2 AHCY ALDH2 TBCE EZR ABI1 CAMK2B CAPN2 PHPT1 CSRP1 ENAH ALDH4A1 | 1.79e-05 | 558 | 224 | 14 | 35063084 |
| Pubmed | GAPDH AZGP1 SUGT1 AHCY DMD EZR FLNB KRT18 PUF60 CAPN2 LAMA5 ACTR2 GTF2I | 1.92e-05 | 488 | 224 | 13 | 31324722 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GAPDH LUZP1 MID1 NUFIP2 AHCY EZR FLNB ABI1 KRT18 RBBP7 PUF60 PRDX4 UBA2 ACTR2 LIG3 GTF2I STRAP CSRP2 ENAH MRPS34 EIF3F | 1.95e-05 | 1149 | 224 | 21 | 35446349 |
| Pubmed | A Large-scale genetic association study of esophageal adenocarcinoma risk. | ERBB2 ATR RB1CC1 BHMT GGH BRAF CAPN2 DIDO1 HAPLN1 LIG3 ALDH4A1 | 1.95e-05 | 351 | 224 | 11 | 20453000 |
| Pubmed | GAPDH USP9Y AHCY AP1M1 NOC4L KRT18 KDM5A RBBP7 PUF60 PRDX4 CHD9 MED1 YES1 USF3 GTF2I HNRNPUL2 ENAH MRPS34 EIF3F LYN HCK | 2.05e-05 | 1153 | 224 | 21 | 29845934 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | AZGP1 ITPR1 SUGT1 MYPN AHCY NOP2 ANAPC5 ANAPC4 EZR RGPD2 TOPBP1 YES1 GTF2I SNW1 KIN STRAP HNRNPUL2 TIMM50 MRPS34 EIF3F TOP2B | 2.10e-05 | 1155 | 224 | 21 | 20360068 |
| Interaction | SOX2 interactions | MARK1 AZGP1 LUZP1 HIRA ITPR2 GGH TNRC18 KIDINS220 PI4KA NUFIP2 NIP7 AHCY NOC4L C3 ALDH2 NOP2 ANAPC5 ANAPC4 EZR P4HA2 RBBP7 PUF60 SMCHD1 CAPN2 NSD1 CHD9 MED1 YES1 JMJD1C SERPINA12 LIG3 GTF2I STRAP HNRNPUL2 PAK1 PAK2 MRPS34 EIF3F HAL | 7.33e-08 | 1422 | 219 | 39 | int:SOX2 |
| Interaction | PAK2 interactions | GAPDH SUGT1 BRAF FLNB ABI1 KRT18 YES1 SNW1 SH3PXD2A SORBS3 PAK1 PAK2 LYN HCK | 1.10e-07 | 216 | 219 | 14 | int:PAK2 |
| Interaction | AR interactions | KDM3A GAPDH KDM4C KDM3B CASZ1 PTK6 HIRA TNRC18 MID1 KRT18 FOLH1 PUF60 SMCHD1 PRDX4 OBSL1 NSD1 AP1M2 DIDO1 MED1 YES1 JMJD1C ACTR2 LIG3 GTF2I SNW1 HNRNPUL2 LYN HCK TOP2B | 1.22e-06 | 992 | 219 | 29 | int:AR |
| Interaction | PML interactions | KDM3A ATR GAPDH AZGP1 KDM3B LUZP1 HIRA ITPR2 NEK4 NUFIP2 AHCY BRD1 NOP2 EZR KRT18 SMCHD1 TOPBP1 MED1 JMJD1C LIG3 GTF2I SNW1 CSRP1 PAK1 PAK2 EIF3F TOP2B | 3.54e-06 | 933 | 219 | 27 | int:PML |
| Interaction | FXR1 interactions | TNIK LUZP1 NUFIP2 AHCY AP1M1 NOP2 BTRC FLNB ABI1 KRT18 CAMK2B DUSP6 DIDO1 YES1 SNW1 STRAP HNRNPUL2 SORBS3 PAK1 PAK2 MAPKBP1 HCK | 5.25e-06 | 679 | 219 | 22 | int:FXR1 |
| Interaction | SLC6A4 interactions | TNIK MARK1 ANKS1B LUZP1 ITPR2 NWD2 OSBPL6 PISD BMP2K PUF60 CAMK2B GRIA4 DGKE YES1 RPH3A ACTR2 HAPLN1 | 6.30e-06 | 437 | 219 | 17 | int:SLC6A4 |
| Interaction | EED interactions | GAPDH OBSCN CASZ1 BRAF NIP7 AP1M1 NOC4L NOP2 BTRC EZR FLNB P4HA2 KRT18 BMP2K KDM5A RBBP7 PUF60 SMCHD1 PRDX4 CAPN2 NSD1 UBA2 LAMA5 DIDO1 FBXO11 ABCF2 ACTR2 LIG3 GTF2I HNRNPUL2 CSRP1 CSRP2 TIMM50 PAK2 EIF3F | 6.38e-06 | 1445 | 219 | 35 | int:EED |
| Interaction | H3-3A interactions | KDM3A KDM4C KDM3B CASZ1 HIRA NIP7 BRD1 EZR KDM5A RBBP7 PUF60 SMCHD1 TOPBP1 NSD1 DIDO1 CHD9 MED1 FOXJ3 JMJD1C LIG3 GTF2I SNAPC4 TOP2B | 7.64e-06 | 749 | 219 | 23 | int:H3-3A |
| Interaction | APEX1 interactions | ERBB2 KDM4C CASZ1 SLIT2 BPHL PROM2 OSBPL7 AP1M1 PISD IFT80 UROD NOP2 ANAPC5 BTRC TBCE BMP2K ATP13A1 PUF60 SMCHD1 TOPBP1 NSD1 DIDO1 CHD9 FOXJ3 LIG3 PDE12 PHPT1 SLC12A4 SORBS3 TOP2B SEC14L2 | 2.02e-05 | 1271 | 219 | 31 | int:APEX1 |
| Interaction | PHF8 interactions | AZGP1 NIP7 ANAPC5 BTRC ANAPC4 TOPBP1 OBSL1 SERPINA12 SNAPC4 LYN | 2.14e-05 | 174 | 219 | 10 | int:PHF8 |
| Interaction | HSPB1 interactions | GAPDH NEK10 LUZP1 PTK6 BRAF AHCY BTRC ARMC6 FLNB ABI1 KRT18 DUSP6 OBSL1 UBA2 RIPK4 YES1 SNW1 NEK8 CSRP1 PAK1 HCK | 3.22e-05 | 708 | 219 | 21 | int:HSPB1 |
| Interaction | KIAA1217 interactions | 3.74e-05 | 115 | 219 | 8 | int:KIAA1217 | |
| Interaction | FBXO6 interactions | QPCTL GAPDH PLA2G15 GGH SEL1L3 AHCY IGSF3 EZR KRT18 APMAP SMCHD1 LAMA5 ABCF2 HAPLN1 GTF2I STRAP ENTPD2 TIMM50 LRP1 EIF3F SORL1 | 3.87e-05 | 717 | 219 | 21 | int:FBXO6 |
| Interaction | WDR19 interactions | 4.15e-05 | 36 | 219 | 5 | int:WDR19 | |
| Interaction | DOK1 interactions | 4.29e-05 | 59 | 219 | 6 | int:DOK1 | |
| Interaction | BIRC3 interactions | ATR GAPDH AZGP1 PLA2G15 AHCY AP1M1 NOC4L ALDH2 NOP2 EZR FLNB ATP13A1 PUF60 CAMK2B APMAP SMCHD1 PRDX4 ABCF2 RIPK4 ACTR2 LIG3 PDE12 GTF2I SNW1 STRAP HNRNPUL2 CSRP2 ENAH TIMM50 MRPS34 TOP2B | 5.06e-05 | 1334 | 219 | 31 | int:BIRC3 |
| Interaction | YAP1 interactions | KDM3A GAPDH KDM3B LUZP1 TNRC18 SUGT1 NUFIP2 AHCY BTRC EZR FLNB RBBP7 SMCHD1 NSD1 UBA2 DIDO1 MED1 YES1 FOXJ3 JMJD1C GTF2I SNW1 STRAP ENAH PAK2 EIF3F LYN | 6.05e-05 | 1095 | 219 | 27 | int:YAP1 |
| Interaction | MDK interactions | 6.07e-05 | 91 | 219 | 7 | int:MDK | |
| Interaction | RLN1 interactions | 6.98e-05 | 93 | 219 | 7 | int:RLN1 | |
| Interaction | LIMA1 interactions | GAPDH LUZP1 NEK4 OSBPL6 BRD1 SH3BP5 EZR FLNB BMP2K OBSL1 YES1 ACTR2 SH3PXD2A PAK1 LYN | 7.54e-05 | 429 | 219 | 15 | int:LIMA1 |
| Interaction | PHLPP1 interactions | LUZP1 KIDINS220 SUGT1 MYPN NUFIP2 BTRC FLNB KRT18 DIDO1 ABCF2 JMJD1C GTF2I SNW1 | 7.65e-05 | 333 | 219 | 13 | int:PHLPP1 |
| Interaction | NUDC interactions | GAPDH AHCY AP1M1 IFT80 BTRC FLNB KRT18 PUF60 DGKE ACTR2 LIG3 SNW1 NEK8 | 8.63e-05 | 337 | 219 | 13 | int:NUDC |
| Interaction | ERO1A interactions | 9.94e-05 | 132 | 219 | 8 | int:ERO1A | |
| Interaction | ADAM15 interactions | 1.04e-04 | 69 | 219 | 6 | int:ADAM15 | |
| Interaction | H3C3 interactions | KDM3A KDM3B HIRA BRD1 NOP2 KDM5A SMCHD1 TOPBP1 NSD1 DIDO1 MED1 FOXJ3 JMJD1C LIG3 GTF2I TOP2B | 1.09e-04 | 495 | 219 | 16 | int:H3C3 |
| Interaction | DCPS interactions | GAPDH ITPR1 NIP7 AP1M1 NOC4L NOP2 ANAPC4 FLNB SMCHD1 AP1M2 ACTR2 HNRNPUL2 LYN TOP2B | 1.11e-04 | 394 | 219 | 14 | int:DCPS |
| Interaction | TUBA1B interactions | PTK6 NEK4 MID1 BTRC ARMC6 ABI1 MID2 KDM5A RBBP7 CAPN2 OBSL1 GRIA4 RIPK4 SNW1 PAK1 EIF3F | 1.17e-04 | 498 | 219 | 16 | int:TUBA1B |
| Interaction | TOP3B interactions | ERBB2 OBSCN KDM3B IREB2 CASZ1 HIRA ITPR2 TNRC18 PROM2 PI4KA NUFIP2 NOP2 IGSF3 ARSJ MID2 ATP13A1 PUF60 NSD1 ARFGEF2 LAMA5 YES1 ACTR2 LIG3 GTF2I SLC12A4 STRAP NEK8 ENTPD2 SORBS3 MAPKBP1 SNAPC4 LYN | 1.29e-04 | 1470 | 219 | 32 | int:TOP3B |
| Interaction | FASLG interactions | 1.50e-04 | 105 | 219 | 7 | int:FASLG | |
| Interaction | MECP2 interactions | MARK1 USP9Y HIRA GGH NWD2 KIDINS220 MAMDC2 NUFIP2 NOC4L NOP2 EZR KDM5A PUF60 CAMK2B APMAP PRDX4 NSD1 DIDO1 CHD9 FBXO11 MED1 LIG3 SNW1 KIN HNRNPUL2 DNM3 MRPS34 EIF3F TOP2B | 1.54e-04 | 1287 | 219 | 29 | int:MECP2 |
| Interaction | CALD1 interactions | GAPDH LUZP1 HIRA ITPR1 ITPR2 EZR FLNB OBSL1 ACTR2 LRP1 TOP2B | 1.61e-04 | 265 | 219 | 11 | int:CALD1 |
| Interaction | HSPA6 interactions | GAPDH PTK6 NEK4 BRAF FLNB ABI1 DUSP6 RIPK4 SNW1 NEK8 PAK1 HCK | 1.61e-04 | 311 | 219 | 12 | int:HSPA6 |
| Interaction | HCN1 interactions | 1.79e-04 | 108 | 219 | 7 | int:HCN1 | |
| Interaction | MDC1 interactions | CALR3 NEK4 BRAF ANAPC5 ANAPC4 FLNB SMCHD1 TOPBP1 OBSL1 NSD1 LIG3 HNRNPUL2 CSRP2 TNKS | 1.85e-04 | 414 | 219 | 14 | int:MDC1 |
| Interaction | INS interactions | BPHL NUFIP2 COL14A1 PISD FLNB KRT18 PUF60 PRDX4 LAMA5 ABCF2 LIG3 GTF2I PHPT1 HNRNPUL2 MRPS34 CYP2U1 | 1.87e-04 | 519 | 219 | 16 | int:INS |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.57e-06 | 24 | 154 | 5 | 485 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 1.26e-04 | 12 | 154 | 3 | 670 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 2.15e-04 | 3 | 154 | 2 | 297 | |
| GeneFamily | Immunoglobulin like domain containing | 2.52e-04 | 193 | 154 | 8 | 594 | |
| GeneFamily | C2 domain containing|Calpains | 2.56e-04 | 15 | 154 | 3 | 975 | |
| GeneFamily | WD repeat domain containing | 4.19e-04 | 262 | 154 | 9 | 362 | |
| GeneFamily | PWWP domain containing | 8.29e-04 | 22 | 154 | 3 | 1147 | |
| GeneFamily | CTD family phosphatases | 1.95e-03 | 8 | 154 | 2 | 1041 | |
| GeneFamily | Fibronectin type III domain containing | 2.50e-03 | 160 | 154 | 6 | 555 | |
| GeneFamily | Autophagy related | 2.74e-03 | 33 | 154 | 3 | 1022 | |
| GeneFamily | Complement system|Sushi domain containing | 3.52e-03 | 36 | 154 | 3 | 492 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 4.50e-03 | 12 | 154 | 2 | 1243 | |
| GeneFamily | Ankyrin repeat domain containing | 4.75e-03 | 242 | 154 | 7 | 403 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM3A ATR KDM4C KDM3B RB1CC1 HIRA ITPR1 NEK4 SLIT2 FCHSD2 KIDINS220 MID1 DMD BTRC FLNB ABI1 BMP2K KDM5A SMCHD1 TOPBP1 CHD9 MED1 FOXJ3 SNW1 KIN ARHGEF10 TNKS CRYBG3 LYN | 2.93e-10 | 856 | 224 | 29 | M4500 |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | GGA2 AZGP1 MTSS1 FCHSD2 AHCY UGT2B15 SH3BP5 LAMA5 CSRP1 ENTPD1 LYN HCK | 1.60e-07 | 199 | 224 | 12 | M9414 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | GGA2 ATR GAPDH RB1CC1 IL18RAP LUZP1 ITPR1 ITPR2 TRANK1 KIDINS220 NUFIP2 SEL1L3 AP1M1 ABI1 KDM5A APMAP SMCHD1 CAPN2 DUSP6 NSD1 UBA2 FBXO11 DGKE MED1 FOXJ3 JMJD1C FCRL6 ACTR2 PAK2 EIF3F LY9 TOP2B SORL1 | 5.24e-07 | 1492 | 224 | 33 | M40023 |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP | ITGA9 IL18RAP PLA2G15 DUSP6 SERPINA12 ENTPD1 PAK1 LRP1 LYN HCK SORL1 | 1.31e-06 | 200 | 224 | 11 | M4545 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | KDM3A ITGA9 ITPR1 OSBPL7 IFT80 CHD9 PLA2R1 SH3PXD2A SORBS3 SNAPC4 | 1.77e-06 | 166 | 224 | 10 | M6826 |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 8.89e-06 | 199 | 224 | 10 | M9420 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | KDM3A OBSCN CEACAM4 KDM3B RB1CC1 HIRA FCHSD2 BRD1 NOP2 KYNU ABI1 RBBP7 SMCHD1 TOPBP1 GPX7 ARFGEF2 UBA2 DIDO1 ABCF2 MED1 ACTR2 SNW1 SLC12A4 PAK2 TNKS EIF3F LY9 LYN TOP2B | 8.96e-06 | 1394 | 224 | 29 | M9585 |
| Coexpression | GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN | 9.29e-06 | 200 | 224 | 10 | M7372 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | KDM3A MTSS1 ITPR1 KIDINS220 BRAF NUFIP2 DUSP6 SLC44A2 PAK1 TOP2B | 9.29e-06 | 200 | 224 | 10 | M7841 |
| Coexpression | HSIAO_LIVER_SPECIFIC_GENES | 1.07e-05 | 249 | 224 | 11 | M13283 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | ERBB2 MARK1 MTSS1 PTK6 FCHSD2 PROM2 NUFIP2 MPPED1 IGSF3 EZR NPR2 MID2 SLC44A2 DIDO1 ENAH DNM3 CRYBG3 | 1.23e-05 | 583 | 224 | 17 | M17454 |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN | 1.74e-05 | 171 | 224 | 9 | M6321 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | ERBB2 GGA2 ATR HIRA ITPR1 IGSF3 OBSL1 LAMA5 GTF2I ARHGEF10 SORL1 | 2.79e-05 | 276 | 224 | 11 | M3063 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | RB1CC1 LUZP1 ITPR2 MID1 SEL1L3 UGT2B15 C1S C3 ALDH2 IGSF3 EZR ABI1 KRT18 SPSB1 CAPN2 DUSP6 SLC44A2 LAMA5 ACTR2 CSRP1 ENAH PAK1 PAK2 LYN HCK TOP2B | 3.84e-05 | 1276 | 224 | 26 | M39173 |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 5.50e-05 | 198 | 224 | 9 | M7610 | |
| Coexpression | GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP | 5.72e-05 | 199 | 224 | 9 | M7491 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP | 5.94e-05 | 200 | 224 | 9 | M4553 | |
| Coexpression | GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 5.94e-05 | 200 | 224 | 9 | M8547 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP | 5.94e-05 | 200 | 224 | 9 | M6418 | |
| Coexpression | HALLMARK_COMPLEMENT | 5.94e-05 | 200 | 224 | 9 | M5921 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH2_UP | 5.94e-05 | 200 | 224 | 9 | M5534 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 5.94e-05 | 200 | 224 | 9 | M9205 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | MARK1 MTSS1 SEL1L3 C3 DMD IGSF3 FLNB KRT18 CAMK2B DUSP6 AP1M2 RIPK4 LYN SORL1 | 6.22e-05 | 473 | 224 | 14 | M4306 |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | ATR MTSS1 KDM3B ITPR2 KIDINS220 ANAPC5 BMP2K DUSP6 TOPBP1 ARFGEF2 CTDSP1 HNRNPUL2 ENTPD1 HAL | 6.80e-05 | 477 | 224 | 14 | M40930 |
| Coexpression | BUSSLINGER_DUODENAL_TUFT_CELLS | 6.93e-05 | 81 | 224 | 6 | M40033 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | AZGP1 MTSS1 BHMT NEK4 GGH BPHL AHCY UGT2B15 ALDH2 IGSF3 FOLH1 YES1 GTF2I STRAP ALDH4A1 | 9.05e-05 | 553 | 224 | 15 | M1475 |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 | 1.05e-04 | 266 | 224 | 10 | M1286 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | TNIK ERBB2 CYP4F8 AZGP1 SEMA3G OLFML3 PTK6 ITPR1 UGT2B15 COL14A1 KRT18 CAMK2B DUSP6 ALDH4A1 MUC6 SEC14L2 SORL1 | 1.17e-04 | 699 | 224 | 17 | M4960 |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP | 1.22e-04 | 172 | 224 | 8 | M2945 | |
| Coexpression | LOPEZ_MESOTHELIOMA_SURVIVAL_DN | 1.28e-04 | 12 | 224 | 3 | M10263 | |
| Coexpression | GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP | 1.32e-04 | 174 | 224 | 8 | M8925 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | TNIK CEACAM4 ITPR1 FCHSD2 CFAP54 NWD2 BPHL MAMDC2 FLNB KRT18 ABCF2 WDR19 PHPT1 ENAH TLE6 | 1.36e-04 | 574 | 224 | 15 | M8215 |
| Coexpression | WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH | 1.50e-04 | 59 | 224 | 5 | M7899 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | CYP4F8 C1S IGSF3 FLNB P4HA2 NPR2 ATP13A1 PUF60 SLC44A2 OBSL1 DIDO1 SLC12A4 LRP1 | 1.68e-04 | 457 | 224 | 13 | M1613 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | PIGN KDM3B HIRA ITPR2 GGH PISD UROD BRD1 ANAPC5 KYNU TBCE ABI1 RBBP7 PRDX4 TOPBP1 UBA2 ABCF2 YES1 ACTR2 GTF2I SNW1 STRAP CAPN7 DHRS9 ALDH4A1 LYN | 1.70e-04 | 1399 | 224 | 26 | M535 |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.82e-04 | 137 | 224 | 7 | M40313 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 1.86e-04 | 183 | 224 | 8 | M8189 | |
| Coexpression | GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 1.86e-04 | 183 | 224 | 8 | M7635 | |
| Coexpression | HALLMARK_COAGULATION | 1.90e-04 | 138 | 224 | 7 | M5946 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | TNIK CEACAM4 ITPR1 FCHSD2 CFAP54 NWD2 BPHL MAMDC2 FLNB KRT18 ABCF2 WDR19 PHPT1 ENAH TLE6 | 2.20e-04 | 600 | 224 | 15 | MM1025 |
| Coexpression | LEE_LIVER_CANCER_E2F1_DN | 2.21e-04 | 64 | 224 | 5 | M15346 | |
| Coexpression | GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN | 2.41e-04 | 190 | 224 | 8 | M6496 | |
| Coexpression | AIZARANI_LIVER_C11_HEPATOCYTES_1 | 2.62e-04 | 298 | 224 | 10 | M39115 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | ERBB2 CYP4F8 GGA2 QPCTL PLA2G15 TNRC18 FLNB P4HA2 ATP13A1 PUF60 APMAP PRDX4 SLC44A2 OBSL1 SLC12A4 LRP1 | 2.73e-04 | 681 | 224 | 16 | M5314 |
| Coexpression | GSE3982_MAC_VS_NEUTROPHIL_DN | 2.87e-04 | 195 | 224 | 8 | M5492 | |
| Coexpression | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP | 3.14e-04 | 69 | 224 | 5 | M836 | |
| Coexpression | GSE13229_MATURE_VS_INTMATURE_NKCELL_DN | 3.18e-04 | 198 | 224 | 8 | M3216 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 3.18e-04 | 198 | 224 | 8 | M6522 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_UP | 3.18e-04 | 198 | 224 | 8 | M9245 | |
| Coexpression | GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP | 3.29e-04 | 199 | 224 | 8 | M9424 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN | 3.29e-04 | 199 | 224 | 8 | M4964 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN | 3.29e-04 | 199 | 224 | 8 | M7472 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 3.29e-04 | 199 | 224 | 8 | M5235 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN | 3.40e-04 | 200 | 224 | 8 | M4638 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 3.40e-04 | 200 | 224 | 8 | M5980 | |
| Coexpression | GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 3.40e-04 | 200 | 224 | 8 | M3277 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN | 3.40e-04 | 200 | 224 | 8 | M3237 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN | 3.40e-04 | 200 | 224 | 8 | M8651 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_2H_BMDC_UP | 3.40e-04 | 200 | 224 | 8 | M3937 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 3.40e-04 | 200 | 224 | 8 | M7831 | |
| Coexpression | GSE39864_WT_VS_GATA3_KO_TREG_DN | 3.40e-04 | 200 | 224 | 8 | M9063 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 3.40e-04 | 200 | 224 | 8 | M9187 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN | 3.40e-04 | 200 | 224 | 8 | M5695 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_DN | 3.40e-04 | 200 | 224 | 8 | M3079 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP | 3.40e-04 | 200 | 224 | 8 | M6963 | |
| Coexpression | SMID_BREAST_CANCER_ERBB2_UP | 3.44e-04 | 152 | 224 | 7 | M3102 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_UP | 3.44e-04 | 152 | 224 | 7 | MM488 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_UP | 3.44e-04 | 152 | 224 | 7 | M366 | |
| Coexpression | JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER | 3.73e-04 | 40 | 224 | 4 | M4988 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL | 4.10e-04 | 41 | 224 | 4 | M39158 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | MTSS1 ITPR1 FCHSD2 SEL1L3 EZR BMP2K SMCHD1 DUSP6 CHD9 ARHGEF10 LYN | 4.48e-09 | 193 | 225 | 11 | 08696a99309f5b088692ddac8cca35413b5e810d |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-08 | 163 | 225 | 10 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-08 | 173 | 225 | 10 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-08 | 147 | 225 | 9 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.82e-08 | 197 | 225 | 10 | fa3cc33c975648172feabb485c3bdd087f1f8ea7 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | TRANK1 OSBPL6 MGAM SMCHD1 SLC44A2 JMJD1C PLA2R1 HAL LYN SORL1 | 7.86e-08 | 200 | 225 | 10 | 95c41f147a1594d49e73cb56d86d301c3115ce20 |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-07 | 161 | 225 | 9 | 274838cebdc7af1db32d309dfe42ef7ccd3c190b | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.08e-07 | 183 | 225 | 9 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 192 | 225 | 9 | 9b8191e66626919cad2c63349c8ef61e9792fcf5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.37e-07 | 193 | 225 | 9 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.37e-07 | 193 | 225 | 9 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.37e-07 | 193 | 225 | 9 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.65e-07 | 194 | 225 | 9 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | severe-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.94e-07 | 195 | 225 | 9 | 73e39005a597e13aea571ae6ae5824d1c7448b71 | |
| ToppCell | droplet-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-07 | 145 | 225 | 8 | f142b86d4da5b71c189da46cbc4beebdc387ffee | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.23e-07 | 199 | 225 | 9 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.23e-07 | 199 | 225 | 9 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-06 | 166 | 225 | 8 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.42e-06 | 169 | 225 | 8 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-06 | 176 | 225 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-06 | 180 | 225 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 181 | 225 | 8 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 183 | 225 | 8 | 63294d66e3ccf152ffe5d1237106764c14390b62 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-06 | 183 | 225 | 8 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 183 | 225 | 8 | 7e5c467fd1b156b928f1611a12ab4affb9f714b7 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.72e-06 | 185 | 225 | 8 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(2)_5-FU / Stress and Cell class | 5.11e-06 | 187 | 225 | 8 | 6bbf0f7fe203274dae8d582652f35cd3187c0065 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-06 | 187 | 225 | 8 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-06 | 187 | 225 | 8 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-06 | 187 | 225 | 8 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 5.31e-06 | 188 | 225 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.53e-06 | 189 | 225 | 8 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.53e-06 | 189 | 225 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.53e-06 | 189 | 225 | 8 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 5.74e-06 | 190 | 225 | 8 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.74e-06 | 190 | 225 | 8 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-06 | 190 | 225 | 8 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-06 | 191 | 225 | 8 | 44631226f59364098a7dd58058e6970a75441009 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.97e-06 | 191 | 225 | 8 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-06 | 191 | 225 | 8 | f892f725a32e704cd18fec2f6d1db82993e7e79a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.20e-06 | 192 | 225 | 8 | 446c61c0d6ba89c619efe87ee495951299953981 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.44e-06 | 193 | 225 | 8 | b52d5661edff83ac4c5fe2bf89d6672016bb827b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-06 | 194 | 225 | 8 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.69e-06 | 194 | 225 | 8 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.95e-06 | 195 | 225 | 8 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.95e-06 | 195 | 225 | 8 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | control-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.95e-06 | 195 | 225 | 8 | ff7956624b36df34e55295b295a71585accf07bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.95e-06 | 195 | 225 | 8 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.95e-06 | 195 | 225 | 8 | bff7685784688425bebd78b0f284a6d4475a9415 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.95e-06 | 195 | 225 | 8 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-06 | 196 | 225 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.21e-06 | 196 | 225 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 7.21e-06 | 196 | 225 | 8 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.21e-06 | 196 | 225 | 8 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | mild-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.21e-06 | 196 | 225 | 8 | 1988088dd7e1ba947339fd1331beed482955e607 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.49e-06 | 197 | 225 | 8 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.49e-06 | 197 | 225 | 8 | 85b5d284e7799335a1829a5d2d56bb0845f5cec5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.49e-06 | 197 | 225 | 8 | da61afba697ec49ca86e062d35a825280da558ac | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.49e-06 | 197 | 225 | 8 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC-29|World / Primary Cells by Cluster | 7.49e-06 | 197 | 225 | 8 | c5bc0e7eb85642b270efc2ba92b13a736af22052 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 7.49e-06 | 197 | 225 | 8 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.49e-06 | 197 | 225 | 8 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.49e-06 | 197 | 225 | 8 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-06 | 198 | 225 | 8 | 0f4052a59c6bd89dab637d6ef1214460d6cbcf55 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.77e-06 | 198 | 225 | 8 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 7.77e-06 | 198 | 225 | 8 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.06e-06 | 199 | 225 | 8 | 1aa963ed5205d6d52262b1597a5d08707a95c3ca | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.06e-06 | 199 | 225 | 8 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.06e-06 | 199 | 225 | 8 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.06e-06 | 199 | 225 | 8 | 6e8a44e46b46e87b81dbfc56fcbbcde166fd00fe | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.06e-06 | 199 | 225 | 8 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.36e-06 | 200 | 225 | 8 | 17ffdbc13332bd3ed1d54abcd7af20267dd4b234 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.36e-06 | 200 | 225 | 8 | 665df8391d2ebcfc6536318612f4992852b5e2b8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.36e-06 | 200 | 225 | 8 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.36e-06 | 200 | 225 | 8 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.36e-06 | 200 | 225 | 8 | 687cfada2d0977e8985e0a73a5804f84f2ca9c52 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.36e-06 | 200 | 225 | 8 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.36e-06 | 200 | 225 | 8 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 151 | 225 | 7 | cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 151 | 225 | 7 | e243b6c76e59035f10519a86399b598dd2123f87 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 151 | 225 | 7 | cdd2ce0969da446616627e3569bbe5a5d9b475bd | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 103 | 225 | 6 | 3a0f02ce52c4e2eda5b987c89317280c08f90cb3 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 155 | 225 | 7 | 8742a4eef328c05ca9a88e499868e45073545094 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-05 | 156 | 225 | 7 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | droplet-Liver-nan-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 157 | 225 | 7 | b72c6a1ed17bfc32d9dec193d934ea82e80b6bd5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 160 | 225 | 7 | 8de1fc75241d9bf2b355afa0e9ef39fea1977177 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 161 | 225 | 7 | 9f02b94e29e60d50e92eaa748ebf0c36d3671bb3 | |
| ToppCell | droplet-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 163 | 225 | 7 | a794540f2d8984f963c08f05175e4bc916fcc224 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 163 | 225 | 7 | 1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3 | |
| ToppCell | droplet-Liver-Hepatocytes-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 163 | 225 | 7 | 7e82c1b7849eca895732df2da74ac6430bd9ba7a | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 163 | 225 | 7 | 03d9fa615d9d02ef98e20f28a10aaa6894dd4960 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 165 | 225 | 7 | dba630e205eb3725195f8861e4af5b745ccfdc74 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 165 | 225 | 7 | b03c8c3110f32257e78838885b313a922af73c98 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 165 | 225 | 7 | a508d66031c1a46b062afbee3cde1cbd0c163a03 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 168 | 225 | 7 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.47e-05 | 169 | 225 | 7 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-05 | 169 | 225 | 7 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 2.57e-05 | 170 | 225 | 7 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 170 | 225 | 7 | 510625bd725d3590cffcd7acd1d42219f6eb1139 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-05 | 171 | 225 | 7 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| Drug | Vanadates | TNIK PIGN ZNF132 MARK1 RB1CC1 USP9Y ITGA9 ZBED10P BRAF MID1 OSBPL6 IFT80 ALDH2 RFESD WDR17 SH3BP5 MGAM FLNB P4HA2 NPR2 ARSJ MID2 CAMK2B GPX7 CHD9 RIPK4 MED1 LIG3 PLA2R1 SLC12A4 CSRP1 LRP1 LYN | 4.61e-07 | 1302 | 222 | 33 | ctd:D014638 |
| Drug | sunitinib | 6.10e-07 | 130 | 222 | 10 | CID005329102 | |
| Drug | monomethyl phthalate | ERBB2 ATR KDM4C RB1CC1 CYP46A1 ITPR1 ITPR2 BRAF C3 ANAPC4 MGAM NPR2 KRT18 PRDX4 CAPN2 DUSP6 ARFGEF2 RIPK4 MED1 ACTR2 GTF2I KIN SLC12A4 CSRP1 HAL TOP2B SEC14L2 | 7.61e-07 | 957 | 222 | 27 | ctd:C517284 |
| Drug | dicyclohexyl phthalate | ERBB2 ATR KDM4C KDM3B CYP46A1 ITPR1 ITPR2 OSBPL2 SUGT1 BRAF C3 ANAPC5 MGAM NPR2 KRT18 PRDX4 CAPN2 DUSP6 RIPK4 MED1 ACTR2 SLC12A4 TOP2B SEC14L2 | 2.44e-06 | 836 | 222 | 24 | ctd:C036042 |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | TRANK1 BTRC P4HA2 KDM5A ARFGEF2 DIDO1 MED1 FOXJ3 PDE12 DHRS9 ALDH4A1 | 2.65e-06 | 189 | 222 | 11 | 1225_UP |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | GGA2 LUZP1 HIRA OSBPL2 NPR2 MID2 NSD1 ARFGEF2 DGKE ENTPD1 SORBS3 | 3.96e-06 | 197 | 222 | 11 | 6519_DN |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A | RB1CC1 ITPR1 OSBPL2 C1S C3 BMP2K KDM5A FOXJ3 HAPLN1 DHRS9 ALDH4A1 | 3.96e-06 | 197 | 222 | 11 | 1223_UP |
| Drug | vandetanib | 5.76e-06 | 99 | 222 | 8 | CID003081361 | |
| Drug | acenaphthenequinone | 1.90e-05 | 17 | 222 | 4 | CID000006724 | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.00e-05 | 192 | 222 | 10 | 4244_UP | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | GGA2 LUZP1 ITPR2 OSBPL2 BPHL ANAPC5 BMP2K FBXO11 ABCF2 ENTPD1 | 2.00e-05 | 192 | 222 | 10 | 6025_DN |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 2.19e-05 | 194 | 222 | 10 | 6173_UP | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | GGA2 PTK6 KIDINS220 BTRC ARMC6 FLT4 LAMA5 GTDC1 ALDH4A1 MAPKBP1 | 2.19e-05 | 194 | 222 | 10 | 3509_DN |
| Drug | Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HG-U133A | CEACAM4 HIRA FCHSD2 FLNB CAPN2 ARFGEF2 ABCF2 MED1 MAPKBP1 LY9 | 2.29e-05 | 195 | 222 | 10 | 1410_UP |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | GGA2 HIRA ITPR1 ARMC6 KDM5A LAMA5 FOXJ3 HNRNPUL2 MRPS34 SNAPC4 | 2.29e-05 | 195 | 222 | 10 | 2122_DN |
| Drug | EKB-569 | 2.30e-05 | 87 | 222 | 7 | CID006445562 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | HIRA KIDINS220 NIP7 ANAPC5 TBCE BMP2K ABCF2 MED1 GTDC1 ALDH4A1 | 2.39e-05 | 196 | 222 | 10 | 987_DN |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; MCF7; HT_HG-U133A | RB1CC1 NEK4 KIDINS220 SPSB1 SMCHD1 ARFGEF2 FBXO11 YES1 JMJD1C CAPN7 | 2.39e-05 | 196 | 222 | 10 | 4786_DN |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; PC3; HT_HG-U133A | 2.39e-05 | 196 | 222 | 10 | 7123_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.39e-05 | 196 | 222 | 10 | 3682_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | TMEM222 LUZP1 KDM5A DIDO1 CHD9 CTDSP1 MED1 ARHGEF10 MRPS34 SNAPC4 | 2.50e-05 | 197 | 222 | 10 | 1732_DN |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | KCNJ1 BTRC ARMC6 NPR2 FLT4 ARHGEF10 ENTPD1 SORBS3 DNM3 SNAPC4 | 2.50e-05 | 197 | 222 | 10 | 6741_DN |
| Drug | Pivampicillin [33817-20-8]; Up 200; 8.6uM; PC3; HT_HG-U133A | MARK1 SLC22A14 COL14A1 ALDH2 KYNU BTRC ENTPD1 DHRS9 LRP1 HAL | 2.50e-05 | 197 | 222 | 10 | 5046_UP |
| Drug | NS-398; Up 200; 10uM; PC3; HT_HG-U133A | 2.61e-05 | 198 | 222 | 10 | 6892_UP | |
| Drug | Khellin [82-02-0]; Up 200; 15.4uM; HL60; HG-U133A | 2.72e-05 | 199 | 222 | 10 | 2004_UP | |
| Drug | Decamethonium bromide [541-22-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | MTSS1 ITPR2 FLT4 CAMK2B OBSL1 GRIA4 HAPLN1 PLA2R1 PDE12 ENTPD1 | 2.84e-05 | 200 | 222 | 10 | 4094_UP |
| Drug | polyproline | GAPDH PTK6 MYPN FLNB ABI1 RIPK4 YES1 PHPT1 ENAH SORBS3 LYN HCK | 3.53e-05 | 295 | 222 | 12 | CID000439587 |
| Drug | PHMPS | 4.94e-05 | 8 | 222 | 3 | CID003033937 | |
| Drug | ponatinib | 5.31e-05 | 68 | 222 | 6 | ctd:C545373 | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 6.86e-05 | 179 | 222 | 9 | 6184_UP | |
| Drug | tert-butyl hydroperoxide | PIGN ERBB2 GAPDH BRAF PI4KA NIP7 SEL1L3 NOC4L ALDH2 UROD ANAPC5 FLNB PRDX4 DUSP6 GPX7 LAMA5 PLA2R1 GTF2I SLC12A4 ARHGEF10 CAPN7 TOP2B | 7.74e-05 | 902 | 222 | 22 | CID000006410 |
| Drug | dimethyl phthalate | ERBB2 ATR MTSS1 CYP46A1 ITPR1 ITPR2 SUGT1 BRAF C3 UROD MGAM NPR2 PRDX4 CAPN2 DUSP6 YES1 ACTR2 TOP2B SORL1 | 7.90e-05 | 714 | 222 | 19 | ctd:C024629 |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | ANKS1B FLNB NPR2 LAMA5 RPH3A IGDCC4 HAPLN1 SLC12A4 CSRP1 SORBS3 DNM3 ALDH4A1 SORL1 | 8.18e-05 | 373 | 222 | 13 | ctd:C540355 |
| Drug | AC1L4MJS | 9.46e-05 | 2 | 222 | 2 | CID000159821 | |
| Drug | MgProtoMe | 1.04e-04 | 10 | 222 | 3 | CID000167508 | |
| Drug | o,p'-DDT | 1.13e-04 | 49 | 222 | 5 | CID000013089 | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A | ITPR2 ANAPC5 CAMK2B HAPLN1 PDE12 SH3PXD2A SORBS3 ALDH4A1 LY9 | 1.17e-04 | 192 | 222 | 9 | 6875_UP |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.17e-04 | 192 | 222 | 9 | 7280_DN | |
| Drug | hydroxyl radicals | CYP4F8 GAPDH USP9Y CYP46A1 PLA2G15 GGH MID1 AHCY C3 ALDH2 UROD ANAPC5 KYNU ANAPC4 MGAM PRDX4 DUSP6 GPX7 CTDSP1 ARSF ENTPD1 ENTPD2 LRP1 DNM3 PAK2 CYP2U1 ALDH4A1 HAL | 1.20e-04 | 1341 | 222 | 28 | CID000000961 |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.22e-04 | 193 | 222 | 9 | 6716_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; HL60; HT_HG-U133A | 1.22e-04 | 193 | 222 | 9 | 1155_DN | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.27e-04 | 194 | 222 | 9 | 2118_DN | |
| Drug | Homocysteine | 1.32e-04 | 195 | 222 | 9 | ctd:D006710 | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 1823_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; HL60; HT_HG-U133A | 1.32e-04 | 195 | 222 | 9 | 2468_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; HL60; HG-U133A | 1.37e-04 | 196 | 222 | 9 | 2031_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; ssMCF7; HG-U133A | ITGA9 IL18RAP CYP46A1 EDDM3A SLC22A14 RPH3A PDE12 SH3PXD2A DHRS9 | 1.37e-04 | 196 | 222 | 9 | 403_UP |
| Drug | Diclofenac sodium [15307-79-6]; Down 200; 12.6uM; PC3; HT_HG-U133A | IREB2 PLA2G15 LUZP1 BMP2K KDM5A SMCHD1 GTDC1 HNRNPUL2 MRPS34 | 1.37e-04 | 196 | 222 | 9 | 5861_DN |
| Drug | sodium 4-phenylbutyrate; Down 200; 100uM; MCF7; HG-U133A | 1.37e-04 | 196 | 222 | 9 | 341_DN | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 1686_DN | |
| Drug | PF-00539745-00 [351321-33-0]; Up 200; 10uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 222 | 9 | 5979_UP | |
| Drug | Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; HL60; HG-U133A | 1.37e-04 | 196 | 222 | 9 | 1744_UP | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; HL60; HG-U133A | 1.42e-04 | 197 | 222 | 9 | 1789_UP | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 2630_UP | |
| Drug | Tranexamic acid [1197-18-8]; Up 200; 25.4uM; HL60; HG-U133A | 1.42e-04 | 197 | 222 | 9 | 1401_UP | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 6100_DN | |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 4963_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 6219_UP | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 5685_DN | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 7146_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; PC3; HT_HG-U133A | 1.42e-04 | 197 | 222 | 9 | 4570_UP | |
| Drug | mg 8 | 1.42e-04 | 11 | 222 | 3 | CID000069414 | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 5485_DN | |
| Drug | Tomatidine [77-59-8]; Up 200; 9.6uM; HL60; HG-U133A | 1.48e-04 | 198 | 222 | 9 | 1754_UP | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; HL60; HG-U133A | 1.48e-04 | 198 | 222 | 9 | 1579_DN | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; HL60; HG-U133A | 1.48e-04 | 198 | 222 | 9 | 1735_UP | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; MCF7; HG-U133A | 1.48e-04 | 198 | 222 | 9 | 342_DN | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 198 | 222 | 9 | 2646_UP | |
| Drug | hydroxylamine | 1.49e-04 | 244 | 222 | 10 | CID000000787 | |
| Drug | ammonium phosphate | 1.50e-04 | 28 | 222 | 4 | CID000024402 | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; HL60; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 2406_UP | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 7311_DN | |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 7016_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A | 1.54e-04 | 199 | 222 | 9 | 122_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.54e-04 | 199 | 222 | 9 | 7380_DN | |
| Drug | Propylthiouracil [51-52-5]; Up 200; 23.4uM; PC3; HT_HG-U133A | SEMA3G SLC22A14 GALNT8 OSBPL7 BTRC CAMK2B RPH3A PDE12 ENTPD1 | 1.54e-04 | 199 | 222 | 9 | 4076_UP |
| Drug | wortmannin; Up 200; 0.01uM; ssMCF7; HG-U133A | MTSS1 IL18RAP CYP46A1 EDDM3A SLC22A14 RPH3A PDE12 SH3PXD2A DHRS9 | 1.60e-04 | 200 | 222 | 9 | 404_UP |
| Disease | Disproportionate short stature | 2.27e-05 | 77 | 217 | 6 | C0878659 | |
| Disease | stomach carcinoma (is_marker_for) | 2.69e-05 | 24 | 217 | 4 | DOID:5517 (is_marker_for) | |
| Disease | Hypoxic Brain Damage | 5.38e-05 | 2 | 217 | 2 | C1140716 | |
| Disease | Anoxic Encephalopathy | 5.38e-05 | 2 | 217 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 5.38e-05 | 2 | 217 | 2 | C1527348 | |
| Disease | Anoxia of brain | 5.38e-05 | 2 | 217 | 2 | C0995195 | |
| Disease | Alzheimer's disease (is_implicated_in) | 5.72e-05 | 132 | 217 | 7 | DOID:10652 (is_implicated_in) | |
| Disease | intestinal cancer (implicated_via_orthology) | 8.70e-05 | 32 | 217 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | carcinoma (implicated_via_orthology) | 1.10e-04 | 64 | 217 | 5 | DOID:305 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.39e-04 | 36 | 217 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | cholic acid glucuronide measurement | 1.61e-04 | 3 | 217 | 2 | EFO_0800574 | |
| Disease | non-Hodgkin lymphoma (implicated_via_orthology) | 1.61e-04 | 3 | 217 | 2 | DOID:0060060 (implicated_via_orthology) | |
| Disease | electrocardiography | NEK10 OBSCN CASZ1 LUZP1 TRANK1 GALNT8 NUFIP2 OSBPL6 JMJD1C LIG3 SH3PXD2A ENTPD1 HCK | 1.66e-04 | 530 | 217 | 13 | EFO_0004327 |
| Disease | pancreatic cancer (is_implicated_in) | 1.85e-04 | 112 | 217 | 6 | DOID:1793 (is_implicated_in) | |
| Disease | Benign neoplasm of stomach | 2.47e-04 | 17 | 217 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.47e-04 | 17 | 217 | 3 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.47e-04 | 17 | 217 | 3 | C0154060 | |
| Disease | X-25937 measurement | 3.20e-04 | 4 | 217 | 2 | EFO_0800937 | |
| Disease | Jeune thoracic dystrophy | 3.20e-04 | 4 | 217 | 2 | cv:C0265275 | |
| Disease | serum gamma-glutamyl transferase measurement | TNIK ITGA9 BHMT ITPR1 TRANK1 UGT2B15 C1S C3 IFT80 ALDH2 ANAPC5 CHD9 YES1 JMJD1C DHRS9 ENAH MUC6 | 4.60e-04 | 914 | 217 | 17 | EFO_0004532 |
| Disease | Stomach Carcinoma | 4.73e-04 | 21 | 217 | 3 | C0699791 | |
| Disease | Cetuximab response | 5.31e-04 | 5 | 217 | 2 | cv:CN077967 | |
| Disease | porphyria (implicated_via_orthology) | 5.31e-04 | 5 | 217 | 2 | DOID:13268 (implicated_via_orthology) | |
| Disease | Panitumumab response | 5.31e-04 | 5 | 217 | 2 | cv:CN077999 | |
| Disease | X-24947 measurement | 5.45e-04 | 22 | 217 | 3 | EFO_0800910 | |
| Disease | Hepatolenticular Degeneration | 7.08e-04 | 24 | 217 | 3 | C0019202 | |
| Disease | Hepatic Form of Wilson Disease | 7.08e-04 | 24 | 217 | 3 | C1527352 | |
| Disease | Necrosis | 7.23e-04 | 55 | 217 | 4 | C0027540 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 7.92e-04 | 6 | 217 | 2 | EFO_0007813, EFO_0010707 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 7.92e-04 | 6 | 217 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | forced expiratory volume | IREB2 CASZ1 CHRNA5 MYPN OSBPL6 ANAPC4 BMP2K RBBP7 SLC44A2 ARFGEF2 MED1 JMJD1C SH3PXD2A DNM3 TOP2B | 7.95e-04 | 789 | 217 | 15 | EFO_0004314 |
| Disease | cancer (implicated_via_orthology) | 8.74e-04 | 268 | 217 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | KDM3A ERBB2 OBSCN RB1CC1 ITGA9 BRAF KCNJ1 NIP7 AP1M1 DMD ANAPC5 FLNB KRT18 ARFGEF2 DGKE NLRP14 PAK1 SORL1 | 1.05e-03 | 1074 | 217 | 18 | C0006142 |
| Disease | Paroxysmal atrial fibrillation | 1.07e-03 | 156 | 217 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 1.07e-03 | 156 | 217 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.07e-03 | 156 | 217 | 6 | C2585653 | |
| Disease | Melanoma, Cloudman S91 | 1.10e-03 | 7 | 217 | 2 | C0009075 | |
| Disease | Melanoma, B16 | 1.10e-03 | 7 | 217 | 2 | C0004565 | |
| Disease | Nephronophthisis, familial juvenile | 1.10e-03 | 7 | 217 | 2 | C1855681 | |
| Disease | X-24574 measurement | 1.10e-03 | 7 | 217 | 2 | EFO_0800897 | |
| Disease | Melanoma, Experimental | 1.10e-03 | 7 | 217 | 2 | C0025205 | |
| Disease | Melanoma, Harding-Passey | 1.10e-03 | 7 | 217 | 2 | C0018598 | |
| Disease | obesity (implicated_via_orthology) | 1.11e-03 | 215 | 217 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Atrial Fibrillation | 1.22e-03 | 160 | 217 | 6 | C0004238 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.24e-03 | 29 | 217 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 1.38e-03 | 30 | 217 | 3 | C0029925 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.38e-03 | 30 | 217 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | cardiovascular measurement, left ventricular function | 1.46e-03 | 8 | 217 | 2 | EFO_0004295, EFO_0004298 | |
| Disease | protein FAM177A1 measurement | 1.46e-03 | 8 | 217 | 2 | EFO_0801948 | |
| Disease | deoxycholic acid glucuronide measurement | 1.46e-03 | 8 | 217 | 2 | EFO_0800575 | |
| Disease | X-17676 measurement | 1.46e-03 | 8 | 217 | 2 | EFO_0800785 | |
| Disease | Ventricular Dysfunction | 1.46e-03 | 8 | 217 | 2 | C0242973 | |
| Disease | pulse pressure measurement | TDRD15 QPCTL NEK10 ITGA9 CASZ1 LUZP1 TRANK1 MYPN OSBPL7 IFT80 BRD1 FLNB P4HA2 KDM5A FOLH1 SPSB1 LAMA5 YES1 RPH3A LIG3 LRP1 | 1.52e-03 | 1392 | 217 | 21 | EFO_0005763 |
| Disease | chemokine (C-C motif) ligand 27 measurement | 1.79e-03 | 70 | 217 | 4 | EFO_0008082 | |
| Disease | atrial fibrillation | 1.80e-03 | 371 | 217 | 9 | EFO_0000275 | |
| Disease | Complement deficiency disease | 1.82e-03 | 33 | 217 | 3 | C0272242 | |
| Disease | 22q11 partial monosomy syndrome | 1.87e-03 | 9 | 217 | 2 | C3266101 | |
| Disease | C3 glomerulopathy | 1.87e-03 | 9 | 217 | 2 | C4087273 | |
| Disease | tyrosine-protein phosphatase non-receptor type 4 measurement | 1.87e-03 | 9 | 217 | 2 | EFO_0802172 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.88e-03 | 71 | 217 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | ERBB2 ATR AZGP1 CASZ1 ITPR1 BRAF UGT2B15 UGT2B17 MMP13 EZR FOLH1 CSRP1 | 2.15e-03 | 616 | 217 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | ERBB2 ATR AZGP1 CASZ1 ITPR1 BRAF UGT2B15 UGT2B17 MMP13 EZR FOLH1 CSRP1 | 2.15e-03 | 616 | 217 | 12 | C0376358 |
| Disease | Colorectal Carcinoma | GAPDH OBSCN GGH BRAF ALDH2 DMD ANAPC4 FOLH1 HAPLN1 LIG3 STRAP LRP1 SORL1 | 2.21e-03 | 702 | 217 | 13 | C0009402 |
| Disease | cystic kidney disease (implicated_via_orthology) | 2.33e-03 | 10 | 217 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Atypical Hemolytic Uremic Syndrome | 2.33e-03 | 10 | 217 | 2 | C2931788 | |
| Disease | Asymmetric crying face association | 2.33e-03 | 10 | 217 | 2 | C0431406 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 2.33e-03 | 10 | 217 | 2 | EFO_0022090 | |
| Disease | alopecia areata (is_marker_for) | 2.33e-03 | 10 | 217 | 2 | DOID:986 (is_marker_for) | |
| Disease | 22q11 Deletion Syndrome | 2.33e-03 | 10 | 217 | 2 | C2936346 | |
| Disease | Schizophrenia | TNIK RB1CC1 CHRNA5 PI4KA NUFIP2 BRD1 SLC25A27 CACNA1F FOLH1 CAMK2B GRIA4 ACTR2 SH3PXD2A LRP1 PAK2 | 2.39e-03 | 883 | 217 | 15 | C0036341 |
| Disease | docosahexaenoic acid measurement | 2.53e-03 | 127 | 217 | 5 | EFO_0007761 | |
| Disease | schizophrenia (is_implicated_in) | 2.65e-03 | 78 | 217 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | Jeune thoracic dystrophy | 2.83e-03 | 11 | 217 | 2 | C0265275 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 2.83e-03 | 11 | 217 | 2 | EFO_0801531 | |
| Disease | Hemolytic-Uremic Syndrome | 2.83e-03 | 11 | 217 | 2 | C0019061 | |
| Disease | dilated cardiomyopathy (is_marker_for) | 2.95e-03 | 39 | 217 | 3 | DOID:12930 (is_marker_for) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.30e-03 | 195 | 217 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.38e-03 | 12 | 217 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 3.38e-03 | 12 | 217 | 2 | EFO_0800291 | |
| Disease | femoral neck bone mineral density | 3.39e-03 | 196 | 217 | 6 | EFO_0007785 | |
| Disease | kidney disease (implicated_via_orthology) | 3.40e-03 | 41 | 217 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | epilepsy | 3.40e-03 | 41 | 217 | 3 | EFO_0000474 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 3.90e-03 | 43 | 217 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | alcohol and nicotine codependence | 3.98e-03 | 13 | 217 | 2 | EFO_0004776 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 3.98e-03 | 13 | 217 | 2 | EFO_0800293 | |
| Disease | Carcinogenesis | 3.98e-03 | 13 | 217 | 2 | C0596263 | |
| Disease | X-19141 measurement | 3.98e-03 | 13 | 217 | 2 | EFO_0800799 | |
| Disease | Nephronophthisis | 3.98e-03 | 13 | 217 | 2 | C0687120 | |
| Disease | platelet component distribution width | CAPN12 MTSS1 TRANK1 KYNU FLT4 BMP2K SLC44A2 LAMA5 JMJD1C ENTPD1 DNM3 PAK2 LYN | 4.10e-03 | 755 | 217 | 13 | EFO_0007984 |
| Disease | descending aortic diameter | 4.10e-03 | 88 | 217 | 4 | EFO_0021788 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.31e-03 | 206 | 217 | 6 | C0152013 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 4.43e-03 | 45 | 217 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Neoplasm of lung | 4.62e-03 | 14 | 217 | 2 | cv:C0024121 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 4.62e-03 | 14 | 217 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | Lung cancer | 4.62e-03 | 14 | 217 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 4.62e-03 | 14 | 217 | 2 | 211980 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 4.62e-03 | 14 | 217 | 2 | EFO_0800283 | |
| Disease | Liver Cirrhosis, Experimental | OLFML3 GGH SPSB4 ALDH2 MMP13 KYNU EZR KRT18 APMAP DUSP6 SLC44A2 HAL HCK | 5.03e-03 | 774 | 217 | 13 | C0023893 |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 5.31e-03 | 15 | 217 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 5.58e-03 | 96 | 217 | 4 | C1319315 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FALEKRGYVKAGPWT | 31 | Q93088 | |
| YPALWKVSAKGEEDK | 71 | Q6P461 | |
| KDDSGSVWKAHYVTP | 461 | P54793 | |
| EYHADGGKVPIKWMA | 876 | P04626 | |
| APGALKVLECHWEKY | 96 | Q14507 | |
| ITKWPGDILAYKEHL | 591 | Q9UG63 | |
| AVYRIQDGEKKPIGW | 196 | P15056 | |
| VLEPLKVVWAKCSGY | 926 | O95696 | |
| EEWLSHVVGAVYAPK | 421 | P59826 | |
| LKWSVPLGHVDAIEY | 696 | O15013 | |
| GNYELAKKVFSPVWD | 1031 | Q96N23 | |
| YPVVLNWSVKGAVKE | 1311 | Q96N23 | |
| YWHKGKTAEGSPLIA | 66 | O75871 | |
| SWKQKYEPLGLDAAG | 371 | Q9UJX5 | |
| VIWSIKSFPGGKEYL | 341 | Q9Y6Q5 | |
| PASWKAAYEKGQAPH | 326 | P0C6C1 | |
| YQDGLKPEGIHKDVW | 261 | Q96L12 | |
| VKSGVWLAYPDINFK | 2426 | Q68DQ2 | |
| IGKAVEDSKPYWEAR | 91 | O60239 | |
| EYIRKLKAGEQLSWP | 241 | Q86V15 | |
| IAAAAYVWIEGTKDP | 456 | Q9HD20 | |
| AAQKGAYPIIFTAWK | 131 | Q6NXE6 | |
| ARKGWTYDSVKTPVQ | 376 | A6NHR8 | |
| SGAYDGKIKVWDLVA | 521 | Q9Y297 | |
| TDDSWKGRPYANQKL | 1531 | Q9Y6D5 | |
| IVWSIKSFPGGKEYL | 341 | Q9BXS5 | |
| FWGEKPNLSYIIGKD | 1611 | P01024 | |
| ADGDPAWAPKNYIEK | 436 | Q8IZP0 | |
| VIKETHKPLGDWSYA | 546 | P30038 | |
| ADAYKGLFEVNPWKR | 166 | Q9HDC9 | |
| YAKKLWTAPELLSGN | 681 | P20594 | |
| AKLESWKEGPYTVDA | 2601 | P11532 | |
| NLYGGKPITTKADIW | 236 | Q9NSY1 | |
| NKTLKVWREDGFYPS | 501 | Q9BYV7 | |
| KHLWDYTFGPEKLNI | 86 | P61160 | |
| KKAGDWYGPAVVAHI | 226 | Q96DT6 | |
| GYAAVWKGKTEKAPA | 726 | Q8TDY8 | |
| KKAYGWLHEDTGPES | 431 | Q9ULI1 | |
| STPLKYEVGDLIWAK | 316 | Q96L73 | |
| KDKYIRAFVSLGAPW | 216 | Q8NCC3 | |
| EALKEWGPKDSLYGS | 226 | Q9NXS2 | |
| DWAAKGPYLLGVKAV | 856 | P48200 | |
| GLWTKDPLGQTEKIY | 156 | Q9NRN5 | |
| YWIDSNKEPHGKAIR | 696 | Q14571 | |
| GLCKVDETPKGWYIQ | 126 | O60870 | |
| FYQDKEGPGWTRVKV | 351 | Q7Z304 | |
| ANVFGIKDWVTPYKI | 21 | Q9UJX4 | |
| KGYFPIHLAAWKGDV | 91 | Q7Z6G8 | |
| SRVDFPATWYKDGQK | 741 | O75147 | |
| VPLGTKFYRVKAVSW | 1576 | Q8TDY2 | |
| WSEYDPGAKGRIKHL | 1466 | O60840 | |
| GYEVVGLDWTVAPKK | 276 | P06132 | |
| VTNNGEAKWLPYKTR | 471 | Q6W4X9 | |
| SPAVTWYKNGKLLSV | 186 | O95256 | |
| SDKYGTTPLVWAARK | 166 | Q9ULH0 | |
| LEKKGPQVRDWSHYF | 116 | P05783 | |
| FAKLKGYAHWPARIE | 16 | Q5TGJ6 | |
| VWKKHPVNVDFLGIY | 831 | P19823 | |
| VEKSELWVYKGQGPD | 1136 | Q14643 | |
| LYWTDDGPKKTISVA | 616 | Q07954 | |
| NIDPIYTKAKNGSWA | 421 | Q5FYB0 | |
| FIKYPNDGDIVWGKV | 2236 | O43451 | |
| IPGALWHIYAGKDVD | 2386 | Q15652 | |
| PSKAWGEVKRQIYVA | 721 | Q04609 | |
| ISSALAWYQQKPGKA | 51 | A0A0B4J2D9 | |
| GWKNTPLSQVKFYRD | 41 | Q6DN72 | |
| KDFWGTVGYREKPQA | 366 | Q5VYM1 | |
| VYAAEKVIGAGKSWH | 126 | P21291 | |
| SWKASLLRAGVYPDK | 621 | Q9UQ16 | |
| YKWPADKENDTGIVG | 56 | Q9Y5L3 | |
| VFELKSTGPRKVGYW | 376 | P48058 | |
| YVLAVKWGEEHIPGS | 2581 | O75369 | |
| LKSEPYGEKADVWAV | 701 | Q6ZWH5 | |
| PVAYKAQGNAWVDKE | 251 | O75564 | |
| VGEYNVFPRTLKWSK | 101 | P45452 | |
| SYPVWEDFINKAGKL | 26 | O43312 | |
| ASSLFRWYKEAKPGA | 191 | Q6L8Q7 | |
| KHPNIVTYKESWEGG | 61 | P51957 | |
| AKYADPVADLLDKWG | 156 | Q9GZU7 | |
| PGSGKTQWALKYAKE | 461 | Q1KMD3 | |
| WIKYSTKPDAVFAGA | 541 | Q2PZI1 | |
| EGKPYNQKSDIWALG | 176 | Q86SG6 | |
| GLPKVYWVEESTARK | 106 | P42356 | |
| GKEKPGALWHIYAAK | 1606 | Q7LBC6 | |
| EVVQVKWPDGKLYGA | 941 | Q9H3R0 | |
| GAKIPDTHLRGYALW | 151 | A0A1B0GTW7 | |
| IKVLSPKYLGSWATG | 111 | Q9UJY4 | |
| GPRGDAWKYSTDVKL | 606 | Q8TE49 | |
| DKKVHWVYQLGEAGP | 2801 | O15230 | |
| PKKAAVWEITGAEFS | 776 | P49916 | |
| AQPWEEIKTSYAGVK | 391 | P49961 | |
| SEVKKFNEWLGSLPY | 126 | O15442 | |
| PWHKYKITLATGEGL | 81 | Q8TAC1 | |
| KWHEGLYCGVAPSAK | 796 | Q9BZF3 | |
| KKVLDIPSKYDWSGA | 1586 | P29375 | |
| EVTKPEGKDYALHWL | 51 | Q16576 | |
| QAHLGPKYVGLWDFK | 6 | Q13882 | |
| DLGAAIWPKKGTAVF | 471 | O15460 | |
| QKPYGKAVDVWALGV | 186 | Q6P2M8 | |
| QWLKEGVELHAGPKY | 4101 | Q5VST9 | |
| VTRKAYGPKVDIWSL | 436 | Q13153 | |
| RWVLVGAPKADSKYS | 61 | Q13797 | |
| TRKAYGPKVDIWSLG | 416 | Q13177 | |
| KEKGVVFAHYGPVWR | 161 | Q7Z449 | |
| VKLRWNPDDYGGIKV | 106 | P30532 | |
| KPIYLSKLGSNFAEW | 1476 | Q13535 | |
| FWAPLLEKAYAKLHG | 176 | Q6ZSI9 | |
| KWLKEHPGYVEDLGA | 2511 | Q3L8U1 | |
| YTAREGAKFPIKWTA | 411 | P08631 | |
| LWYVHKPSDADGKLI | 716 | O75054 | |
| DKTGWSYALEKPNTG | 256 | Q9P2H3 | |
| PKSGWADAKYVLEAH | 276 | P42357 | |
| GKEKPGALWHIYAAK | 1166 | Q9Y4C1 | |
| VYAAEKIIGAGKPWH | 126 | Q16527 | |
| KWGLVPTHAYAVLDI | 451 | Q9Y6W3 | |
| DWAKKYGPVVRVNVF | 66 | Q9Y6A2 | |
| EKAPYEWKNLDGISH | 246 | Q92820 | |
| KKVSPNELILGWYAT | 161 | O00303 | |
| PWKESFQQLYKGAHV | 231 | Q86XK2 | |
| RSKDDPGKGSYWAID | 141 | Q9UPW0 | |
| VKWDAVPGASGYLIL | 461 | Q05707 | |
| KNRLHIYWDFKPGGA | 576 | Q9NY28 | |
| DIVFYKTLKPWLGDG | 121 | P98187 | |
| SDFYPGAVKVAWKAD | 31 | P0CF74 | |
| PNDKTKFYAAGLVSW | 641 | P09871 | |
| KAGYKVGAAEPAARW | 6 | B7Z1M9 | |
| IHIGGRIAPKTVWDY | 1091 | Q9BTC0 | |
| DVQKGKYWDTPLHAA | 226 | Q8WWX0 | |
| RYPPAAQEHSKAWKG | 476 | Q86V48 | |
| KGAEKSVLYSWTPRE | 181 | Q9HBG7 | |
| KKYDGPEVDVWSLGV | 231 | Q9P0L2 | |
| EYTAREGAKFPIKWT | 396 | P07948 | |
| HSIYVWDVRDPKKVG | 366 | O60336 | |
| WDVRDPKKVGKVYSA | 371 | O60336 | |
| ISSALAWYQQKPGKA | 51 | P0DP09 | |
| GIIAWTHGDPRKVIY | 51 | Q8IWA5 | |
| YDDANKKWVPAGGST | 16 | Q8N8S7 | |
| GLHYVDNKGFPTWLK | 46 | P15311 | |
| YEVLASKLGKQWTPL | 206 | P52429 | |
| ASQYLKRDWPGVKAD | 61 | O94868 | |
| LVKGLTWDPVGKYIA | 176 | P54198 | |
| KYLVAPDGKVVGAWD | 146 | Q96SL4 | |
| RKHLYKGEIAPFSWA | 426 | Q4AE62 | |
| PASGVKEEWYARITK | 451 | P78347 | |
| KKLFTVVAWDPRGYG | 86 | Q86WA6 | |
| KELGPYSSKTRGIEW | 61 | P17655 | |
| YAAGKDAKIFWIPLS | 281 | Q9BPW9 | |
| GEFKYKQIPISDHWS | 251 | Q16828 | |
| QDGWIYPDAKKRSLI | 156 | Q9Y267 | |
| PYKVADIGLAAWGRK | 6 | P23526 | |
| AIAKAGIPVYAWKGE | 91 | P23526 | |
| KHLWKPAVEAYGEFL | 161 | O76054 | |
| AVKAFWGAKASTPEV | 246 | Q9HBV2 | |
| LPKEEITYSWKFAGG | 176 | W5XKT8 | |
| AHPLEKSKWEGNYLF | 131 | Q9BVI4 | |
| PWNVASLIYETKGEK | 196 | P02748 | |
| YWKATNAGPLDKILH | 191 | Q15648 | |
| PLKGWHKRYFVLEDG | 61 | Q9BZF2 | |
| TVPGVRNYGFWDKDK | 231 | P10915 | |
| KRPAGWSVQAKVDVY | 766 | Q2WGJ9 | |
| WDYPAKQEDKGRAKG | 201 | P82930 | |
| LRKEAYGKPVDIWAC | 186 | Q13554 | |
| EHVKSFSWGIDPYDK | 246 | Q92673 | |
| VAKNPEAAIEWYAKG | 706 | Q68CR1 | |
| DANGYSDPFVKLWLK | 581 | Q9Y2J0 | |
| AIEWDGKIYKAGQLV | 601 | A6NHR9 | |
| RGYESDPVKAWKEAQ | 1101 | Q02880 | |
| QYTDKHGEVCPAGWK | 236 | Q13162 | |
| AAAAAVVAAGDKWKP | 21 | Q9UHX1 | |
| YGILPAKGKHWSEEA | 1851 | B5MCY1 | |
| GRAKYWVERAAKLFP | 111 | P0DJD1 | |
| KVWIKPGAEQSFLYG | 96 | Q9Y221 | |
| DPSKIKWGDAGAEYV | 81 | P04406 | |
| KEWAKSTGYDPVKLF | 241 | Q9UBT2 | |
| DKALSIAPGVSVKYW | 846 | Q8IZU2 | |
| YIRSKNWAKVGDLLP | 876 | Q8NEZ3 | |
| DPLGKWSKTGLVVYD | 336 | P46087 | |
| PAAESKEIVRGYKWA | 36 | Q9NRX4 | |
| VSLQGKDAWLPLHYA | 611 | P57078 | |
| LWGIDPVSYESFKKQ | 306 | Q9H1P3 | |
| QSNWGIRKPDTDYFK | 1336 | Q13018 | |
| WSAYLEKGDIVEKHG | 381 | Q9UP95 | |
| VGKTYGLWKCVLPEE | 296 | Q9Y3F4 | |
| SPRNYKALSEVQGWK | 26 | Q8IW75 | |
| GWADKYHGKTIPIDG | 151 | P05091 | |
| KKAGDWYGPSLVAHI | 241 | Q86TL0 | |
| VKWFYHPEETSPGKQ | 2856 | O15417 | |
| QKEHSGGKPFRWYKD | 161 | P52740 | |
| ALKNAVEIYAWAPKP | 1161 | Q9UKE5 | |
| GSEGPSYAKKVALWL | 56 | Q3ZCQ8 | |
| KRPLSYKGAVAQVLW | 291 | Q5GH72 | |
| NRVDGSKPIWKYETG | 271 | Q7Z417 | |
| LCLKYGAPEDWELKT | 421 | Q15813 | |
| ANVTYLKGELPAWAA | 706 | Q8N271 | |
| GKKLYPVVSAVWGHC | 206 | Q96A44 | |
| GKKLYPVVSAVWGHC | 206 | Q96BD6 | |
| GEKEGWAPASYIDKR | 491 | Q5TCZ1 | |
| KLAGHWEVALYKSVP | 101 | Q9UG56 | |
| WNYTPLHEAAIKGKI | 281 | O95271 | |
| GLAYKSAPKHEWIGK | 556 | O15344 | |
| VAGAHAPSIVWYKDE | 701 | P35916 | |
| VFGKSEDEHYPLWKS | 116 | O95847 | |
| VGAQDDPLAYWEKKR | 206 | Q96FA7 | |
| DSKGQKTYAPSFIWV | 706 | Q9HBX9 | |
| KRWVKYEGIGPVDES | 116 | O60504 | |
| SDWVKSEYKEPGIAR | 871 | O94813 | |
| CLYDDPTIHWKGNLK | 116 | Q68DE3 | |
| ISNWKNAKGYTIPLD | 251 | Q13573 | |
| SPYTRNWDKLVGEIK | 281 | Q9Y2Z0 | |
| KKIVRGPASDWYDAL | 2061 | O00507 | |
| YEDVSAVAKGWKENP | 106 | O95427 | |
| GKYVSVGAFVKTWLP | 176 | Q9H0R3 | |
| YPGKIDVHWTRAGEV | 231 | P25311 | |
| GEKPLKSGVWEEIYS | 586 | Q9UK13 | |
| EYENVGNAASKWPKV | 16 | Q8NB50 | |
| ELIEKYGVGHWAKIA | 466 | Q5SXM2 | |
| WPKAGKSLEVYALFS | 316 | Q9NS98 | |
| KKWDQFYSEVLGRPT | 231 | P54855 | |
| GIAYKSAPKNEWIGK | 606 | Q9UJV3 | |
| HVYWEKAEQAGSPLL | 1051 | O15050 | |
| TKGRTAYNPALIWKE | 1291 | O15050 | |
| DYSKGVSPLEWKGSV | 246 | Q96PF1 | |
| GGSKYEAAKKWNLPA | 701 | Q92547 | |
| PDGHVTKYDLNWLVK | 121 | Q9NVH6 | |
| KKWDQFYSEVLGRPT | 231 | O75795 | |
| PDGVKSIVVKGYNIW | 421 | Q9H808 | |
| YTARQGAKFPIKWTA | 426 | P07947 | |
| WGYRFAPIVSKTKEG | 321 | P48048 | |
| LDKWAKIAAYGHEVG | 91 | Q16719 | |
| KIAAYGHEVGKRPWI | 96 | Q16719 | |
| YPGEKAWSVSLKIFG | 66 | Q86W24 | |
| LLIQPAKKSDAGWYT | 1231 | Q86TC9 |